Document:

Exhibit
10.5

 

EXCHANGE
AGREEMENT

 

THIS
EXCHANGE AGREEMENT (the “Agreement”) is made as of the 16th day of February 2021, by and between, Madison
Technologies, Inc., a Nevada corporation (the “Company”), and such persons listed on Schedule I who have executed
a signature page to this Agreement (each, an “Investor”).

 

WHEREAS,
the Investor has previously acquired various securities from the Company in the form of promissory notes and/or series A convertible
preferred stock issued by the Company, as set forth on Schedule I (the “Securities”).

 

WHEREAS,
the Company has authorized a new series of Convertible Preferred Stock of the Company designated as Series D Convertible Preferred Stock,
par value $0.001 per share (the “Series D Preferred Stock”), the terms of which are set forth in the Certificate of
Designations for such series of Series D Preferred Stock (the “Certificate of Designations”) in the form attached
hereto as Exhibit A.

 

WHEREAS,
subject to the satisfaction of the conditions set forth herein, the Company and each Investor desire to enter into a transaction wherein
the Company shall issue such aggregate number of shares of Series D Preferred Stock in exchange for each of the Securities as set forth
on Schedule I.

 

NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.
Exchange. The closing of the Exchange (the “Closing”) will occur on or before February __, 2021 (or such later
date as the parties hereto may agree) following the satisfaction or waiver of the conditions set forth herein (such date, the “Closing
Date”). On the Closing Date, subject to the terms and conditions of this Agreement, each Investor shall, and the Company shall,
pursuant to Section 3(a)(9) of the Securities Act of 1933 (the “Securities Act”), exchange the Securities for (i)
shares of the Series D Preferred Stock [and (ii) Options (as defined below) to purchase shares of the Company’s wholly-owned subsidiary,
CZJ License, Inc., a Nevada corporation (“Sub”) (in the amounts and pursuant to the terms set forth in Section 1.8
below). At the Closing, the following transactions shall occur (such transactions in this Section 1, the “Exchange”):

 

1.1.
Delivery of Securities. On the Closing Date, the Company shall issue the Series D Preferred Stock [and Options] to each Investor
(or its designees); provided that each Investor has complied with its obligations in this Section 1. As soon as commercially practicable
after the Closing Date, the Company shall deliver a certificate evidencing the Series D Preferred Stock to the Investor. On the Closing
Date, the Investor shall be deemed for all corporate purposes to have become the holder of record of the Series D Preferred Stock and
shall have the right to convert the Series D Preferred Stock, irrespective of the date the Company delivers the certificate evidencing
the Series D Preferred Stock to each Investor.

 

    	 

     

    

 

1.2.
No Rights Following Exchange. Upon receipt of the Series D Preferred Stock [and Options] in accordance with Section 1.1,
each Investor’s rights under the Securities shall be extinguished (including, without limitation, the rights to receive, as applicable,
any principal, premium, make-whole amount, accrued and unpaid interest, dividends or other payment thereon or any other shares of common
stock, par value $0.001 per share (“Common Stock”) with respect thereto (whether upon in connection with a fundamental
transaction, event of default or otherwise)). In consideration for the issuance of the Series D Preferred Stock and the Options, each
Investor hereby irrevocably waives any obligations of the Company under the Securities or any promissory note, purchase agreement, security
agreement, pledge agreement, warrant, guarantee or any other document executed in connection with the issuance of the Securities.

 

1.3.
Further Assurances. The Company and each Investor shall execute and/or deliver such other documents and agreements as are customary
and reasonably necessary to effectuate the Exchange.

 

1.4.
Termination Before Closing. If the Closing has not occurred on or prior to April 12, 2021, any Investor shall have the right,
by delivery of written notice to the Company to terminate this Agreement (such date, the “Termination Date”). From
the date hereof until the earlier of (x) the Closing Date and (y) the Termination Date, each Investor shall forbear from taking any actions
with respect to the Securities not explicitly set forth herein, including, without limitation, conversions, exercises, redemptions, exchanges
or delivery of written notice to the Company to require the conversion, exercise, redemption or exchange of any of the Securities.

 

1.5.
Representations and Warranties True at Closing. It shall be a condition to the obligation of the Investor on the one hand and
Company on the other hand, to consummate the Exchange contemplated hereunder that the other party’s representations and warranties
contained herein are true and correct on the Closing Date with the same effect as though made on such date, unless waived in writing
by the party to whom such representations and warranties are made.

 

1.6.
Deliveries. At or before the Closing, each Investor shall deliver or cause to be delivered to the Company, (i) the Securities
held by such Investor free and clear of all liens, encumbrances, security interests, options or other purchase rights, equities, charges,
claims, pledges, defects of title or other restrictions of any kind (other than federal and state securities laws) (ii) the executed
Agreement and (iii) other items required to effectuate the Exchange.

 

1.7.
Intentionally Omitted.

 

1.8.
Options.

 

1.8.1.
The Company shall issue to each Investor an exclusive option to acquire shares of common stock of the Sub in the amounts set forth on
Schedule II hereto for a payment of $10.00 per share (the “Options”).

 

    	2 

     

    

 

1.8.2.
Each Investor may deliver notice to the Company of its desire to exercise (“Exercise Notice”) its Options at any time
during the period from the Closing Date through February 16, 2022. Within ten (10) days of receipt by the Company of Exercise Notices
from Investors holding Options covering a majority of the shares of the Sub (the “Majority”), the Company shall deliver
a written notice to all Investors (the “Company Notice”) notifying them that the Company has received such Exercise
Notices from the Majority and the date of the closing of the purchase of the shares of Sub by such Majority (the “Sub Closing”),
which date will be not less than sixteen (16) days from the date of such notice. Such Company Notice shall also include a notification
to any Investor who wishes to exercise its Options but has not delivered an Exercise Notice, that it must do so within fifteen (15) days
following the date of the Company Notice in order to participate in the Sub Closing. In the event the Company does not receive an Exercise
Notice from any Investor, then such Investor’s Options shall be automatically cancelled (the “Cancelled Options”)
on the sixteenth (16th) day following the date of the Company Notice and such Investors will have no rights and the Company no additional
obligations under such Cancelled Options.

 

1.8.3.
The shares of the Sub underlying the Cancelled Options shall be divided pro rata among the Investors who timely deliver Exercise
Notices (“Participating Investors”). Each Participating Investor’s pro rata share shall be equal to the
product obtained by multiplying: (i) the aggregate number of shares underlying the Cancelled Options, by (ii) a fraction, the numerator
of which is the number of Options owned by such Investor on the date the Company Notice is delivered and the denominator of which is
the total number of Options granted on the Closing Date. On the date of the Sub Closing, each Participating Investor shall deliver the
exercise price for its Options to the Company in cash, and the Company shall issue to each Investor the number of shares of the Sub underlying
their Options plus any shares underlying Cancelled Options, if any, to which they are entitled.

 

2.
Representations and Warranties of the Company. The Company hereby represents and warrants to each Investor that:

 

2.1.
Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing
under the laws of the State of Nevada. The Company is duly qualified to transact business and is in good standing in each jurisdiction
in which the failure to so qualify would have a Material Adverse Effect (as defined below) on its business or properties. As used in
this Agreement, “Material Adverse Effect” means any material adverse effect on the business, properties, assets, liabilities,
operations, results of operations, condition (financial or otherwise) or prospects of the Company and its Subsidiaries, if any, individually
or taken as a whole, or on the transactions contemplated hereby or on the Exchange (as defined below) or by the agreements and instruments
to be entered into (or entered into) in connection herewith or therewith, or on the authority or ability of the Company to perform its
obligations under this Agreement or the Exchange.

 

2.2.
Authorization. All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization,
execution and delivery of this Agreement and the other Exchange and the performance of all obligations of the Company hereunder and thereunder,
and the authorization of the Exchange, the issuance (and reservation for issuance) of the Series D Preferred Stock have been taken on
or prior to the date hereof.

 

    	3 

     

    

 

2.3.
Valid Issuance of the Series D Preferred Stock. The Series D Preferred Stock shares when issued and delivered in accordance with
the terms of this Agreement, for the consideration expressed herein, and the Common Stock when issued in accordance with the terms of
the Certificate of Designations, for the consideration expressed therein, will be duly and validly issued, fully paid and non-assessable.

 

2.4.
Consents; Waivers. No consent, waiver, approval or authority of any nature, or other formal action, by any individual, a limited
liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization and a government or any department
or agency thereof (each, a “Person”), not already obtained, is required in connection with the execution and delivery
of this Agreement by the Company or the consummation by the Company of the transactions provided for herein and therein.

 

2.5.
Acknowledgment Regarding Investor’s Purchase of Series D Preferred Stock. The Company acknowledges and agrees that each
Investor is acting solely for itself and not any other Investor in the capacity of arm’s length purchaser with respect to this
Agreement and the Exchange and the transactions contemplated hereby and thereby and that each Investor is not (i) an officer or director
of the Company, (ii) an “affiliate” of the Company (as defined in Rule 144 promulgated under the Securities Act), or (iii)
to the knowledge of the Company, a “beneficial owner” of more than 9.9% of the shares of Common Stock (as defined for purposes
of Rule 13d-3 under the Exchange Act). The Company further acknowledges that each Investor is not acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to the Exchange and the transactions contemplated hereby and thereby, and any
advice given by the Investor or any of its representatives or agents in connection with the Exchange and the transactions contemplated
hereby and thereby is merely incidental to the Investor’s acceptance of the Series D Preferred Stock. The Company has not (i) received
any consideration from each Investor for the Series D Preferred Stock received in the Exchange, other than the Securities, (ii) paid
any commission or remuneration for the solicitation of the Exchange or (iii) offered any shares of the Series D Preferred Stock to any
Person other than each Investor.

 

3.
Representations and Warranties of the Investor. Each Investor hereby represents, warrants and covenants that:

 

3.1.
Authorization. The Investor has full power and authority to enter into this Agreement, to perform its obligations hereunder and
to consummate the transactions contemplated hereby and has taken all action necessary to authorize the execution and delivery of this
Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated hereby.

 

3.2.
Exchange Only. The Investor is a current holder of Securities and has not provided any consideration to the Company for the Series
D Preferred Stock received in the Exchange other than the Securities. Each Investor understands that: (i) the Securities have not been
and are not being registered under the Securities Act or any state securities laws, and the Series D Preferred Stock issued in the Exchange
may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, (B) pursuant to Rule 144, or
(C) pursuant to another exemption from registration under the Securities Act, including but not limited to Section 3(a)(9) thereunder.

 

    	4 

     

    

 

3.3.
No Governmental Review. The Investor understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Series D Preferred Stock or the fairness or suitability of the
investment in the Series D Preferred Stock nor have such authorities passed upon or endorsed the merits of the offering of the Series
D Preferred Stock.

 

3.4.
Validity; Enforcement; No Conflicts. This Agreement has been duly and validly authorized, executed and delivered on behalf of
the Investor and shall constitute the legal, valid and binding obligations of the Investor enforceable against the Investor in accordance
with their respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable
creditors’ rights and remedies.

 

3.5.
Ownership of Securities. The Investor owns and holds, beneficially and of record, the entire right, title, and interest in and
to the Securities free and clear of all rights and liens (other than pledges or security interests (x) arising by operation of applicable
securities laws and (y) that the Investor may have created in favor of a prime broker under and in accordance with its prime brokerage
agreement with such broker). The Investor has full power and authority to transfer and dispose of the Securities to the Company free
and clear of any right or lien. Other than the transactions contemplated by this Agreement, there is no outstanding, plan, pending proposal,
or other right of any Person to acquire all or any part of the Securities or any shares of Common Stock issuable upon conversion of the
Securities.

 

3.6.
Release of Reserve. If prior to the date hereof, the Investor had a share reserve with the Company’s transfer agent, it
has instructed such transfer agent to release the amount shares of Common Stock the Investor has reserved of the maximum number of shares
of Common Stock issuable upon conversion of any of the Securities.

 

4.
Additional Covenants.

 

4.1.
Fees and Expenses. Except as otherwise set forth above, each party to this Agreement shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement.

 

4.2.
Legal Opinions. The Company agrees to take all actions, including, without limitation, the issuance by its legal counsel, or any
legal counsel reasonably acceptable to the Company, of any legal opinions, in the connection of any sale of Common Stock issued upon
conversion of Series D Preferred Stock by any Investor; provided that each such investor provides customary representation letters and
all other such documentation as required by counsel to the Company to issue a legal opinion.

 

    	5 

     

    

 

5.
Miscellaneous

 

5.1.
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit
of and be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this Agreement, express
or implied, is intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any rights,
remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

5.2.
Governing Law; Exclusive Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of
this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of
any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state
or federal courts sitting in New York County, New York, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action
or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to
such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

5.3.
Notices. All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall
be sufficiently given if delivered to the addressees in person, by FedEx or similar overnight next business day delivery, or by email
followed by overnight next business day delivery, to the address as provided for on the signature page to this Agreement.

 

5.4.
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company
and the Investor.

 

5.5.
Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall
be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall
be enforceable in accordance with its terms so long as this Agreement as so modified continues to express, without material change, the
original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)
in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization
of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the
prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of
the prohibited, invalid or unenforceable provision(s).

 

5.6.
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument.

 

5.7.
Survival. Sections 4 and 5 of this Agreement shall survive the Closing and delivery of the Series D Preferred Stock.

 

[SIGNATURES
ON THE FOLLOWING PAGE]

 

    	6 

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

	 	MADISON
    TECHNOLOGIES, INC.
	 	 	 
	 	By:	 
	 	Name:	Jeffrey
    Canouse
	 	Title:	Chief
    Executive Officer

 

	 	Address
    for Notices:
	 	 
	 	240
    Vaughan Drive
	 	Suite
    200
	 	Alpharetta,
    GA 30009
	 	Email:
    jeffcanouse@gmail.com

 

    	 

     

    

 

IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

	 	INVESTORS:

 

	 	By:	
	 	Name:	
	 	Title:	

 

	 	Address
    for Notices:
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	Email:	 
	 	 	 
	 	SSN#:
    	

 

		[TO
  BE COMPLETED FOR EACH INVESTOR]

 

    	 

     

    

 

EXHIBIT
A

Certificate
of Designations

 

[See
attached]

 

    	 

     

    

 

Schedule
I

 

Schedule
IIExhibit
10.6

 

SECURITIES
PURCHASE AGREEMENT

 

THIS
SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of February 17, 2021, by and among Madison Technologies,
Inc., a Nevada corporation (the “Company”) and the purchasers from time to time party hereto as “Purchasers”
(together with their respective successors and assigns, each, a “Purchaser” and collectively, the “Purchasers”).

 

RECITALS

 

A.
The Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506(b) of Regulation D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission under the Securities Act.

 

B.
Each of the Purchasers, wishes to purchase, and the Company wishes to sell at closing, upon the terms and conditions stated in this Agreement,
the Securities (as defined herein), all in the amounts and for the price set forth on Schedule 1 hereto.

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company, the Purchasers and the Agent hereby agrees as follows:

 

ARTICLE
1

DEFINITIONS

 

1.1
Defined Terms. In addition to terms defined elsewhere in this Agreement or in any supplement, amendment or exhibit hereto, when
used herein, the following terms shall have the following meanings:

 

(a)
“Action” has the meaning specified for such term in Section 3.1(z).

 

(b)
“Additional Financing” means any incurrence of Indebtedness or issuance of convertible securities incurred or entered
into by the Company or any of its Affiliates or through special purpose vehicle or joint venture structures, but excluding financing
in the form of common equity investments in the Company or any of its Affiliates. For the avoidance of doubt, it is understood and agreed
that the term “Additional Financing” shall not include the Notes or any other financing provided by the Purchasers in connection
with the Transaction Documents.

 

(c)
“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled
by or is under common control with a Person, as such terms are used in and construed under Rule 405 of the Securities Act, including,
among others, executive officers, directors, large stockholders, subsidiaries, parent entities and sister companies.

 

(d)
“Agent” has the meaning specified for such term in the Security Agreement.

 

    	-1-

    	 

    

 

(e)
“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United
States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action
to close.

 

(f)
“Closing Date” means the Trading
Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions
precedent to the parties’ obligations hereunder have been satisfied or waived, including (i) each Purchaser’s obligation
to pay the Purchase Price as described in Section 2.5, and (ii) the Company’s obligations to deliver the Securities. 

 

(g)
“Closing Fee” means a cash fee in the aggregate amount of $660,000 payable by the Company to the Purchasers on the
Closing Date (or such later date as the Purchasers may otherwise agree) (which amount shall be in addition to the original issue discount
applicable to the Notes).

 

(h)
“Collateral” shall have the meaning
ascribed to such term as set forth in the Security Agreement.

 

(i)
“Commitment Shares” means shares of the Company’s Series F Convertible Preferred Stock (convertible into 192,073,017
shares of the Company’s Common Stock) to be issued to the Purchasers at Closing.

 

(j)
“Commitment Conversion Shares” means all shares of Common Stock issuable upon conversion of any of the Commitment
Shares.

 

(k)
“Common Stock” means (i) the Company’s common stock, par value $0.001 per share, and (ii) any capital stock
into which such common stock shall have been changed or any share capital resulting from a reclassification of such common stock.

 

(l)
“Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder
thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Stock.

 

(m)
“Communications Act” shall mean the Communications Act of 1934, as amended, and any similar or successor federal statute.

 

(n)
“Communications Laws” shall mean the Communications Act and the FCC Regulations, as each may be in effect from time
to time.

 

(o)
“Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that
Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the
Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will
be protected (in whole or in part) against loss with respect thereto.

 

    	-2-

    	 

    

 

(p)
“Control Agreement” means, with respect to any deposit account, any securities account, commodity account, securities
entitlement or commodity contract, an agreement, in form and substance satisfactory to Agent, among Agent, the financial institution
or other Person at which such account is maintained or with which such entitlement or contract is carried and the Company or the Subsidiary
maintaining such account, effective to grant “control” (as defined under the applicable UCC) over such account to Agent.

 

(q)
“Conversion Date” has the meaning set forth in the Notes; provided, that no Conversion Date shall occur prior to the
date on which the Shareholder Approval is received.

 

(r)
“Conversion Shares” means all shares of Common Stock issuable upon conversion of any portion of any Note (including,
at any Purchaser’s election pursuant to the conditions set forth in the Notes, accrued and unpaid interest thereon), but solely
to the extent and subject to any conditions set forth in the Notes.

 

(s)
“Dollar(s)” and “$” means lawful money of the United States.

 

(t)
“Effective Date” means the date that the initial Registration Statement filed by the Company pursuant to the Registration
Rights Agreement is first declared effective by the Commission.

 

(u)
“Event of Default” shall have the meaning set forth in the Notes.

 

(v)
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

(w)
“Exchange Agreement” means the Share Exchange Agreement, dated as of the date hereof, by and among Madison Technologies,
Inc., a Nevada corporation, as buyer, Sovryn Holdings, Inc., a Delaware corporation, as the “Company” and the shareholders
of the Company identified on Exhibit A attached thereto.

 

(x)
“Exempt Issuance” means the issuance of (a) shares of Common Stock or options to employees, officers, consultants,
advisors or directors of the Company in consideration of services to the Company pursuant to any stock or option plan duly adopted for
such purpose by a majority of the members of the Board of Directors or a majority of the members of a committee of directors established
for such purpose, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities
exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided
that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise, exchange or conversion price of such securities, and (c) securities issued pursuant to the Subsequent Equity Financing,
so long as such issuance is based on an enterprise valuation of not less than $45,000,000.

 

    	-3-

    	 

    

 

(y)
“FCC” shall mean the Federal Communications Commission and any successor or substitute governmental commission, agency,
department, board or authority performing functions similar to those performed by the Federal Communications Commission on the Closing
Date.

 

(z)
“FCC License” shall mean any license required under the Communications Laws.

 

(aa)
“FCC Enforcement Provisions” shall have the meaning set forth for such term in the Security Agreement.

 

(bb)
“FCC Regulations” shall mean all rules, regulations, written policies, orders and decisions of the FCC under the Communications
Act.

 

(cc)
“Funding Account” means a deposit account in the name of Agent into which $14,500,000 of the Purchase Price shall
be deposited on the Closing Date.

 

(dd)
“Funding Release” has the meaning specified for such term in Section 2.5.

 

(ee)
“Funding Release Date” means any date on which any funds are released from the Funding Account pursuant to Section
2.5.

 

(ff)
“Funding Release Request” means a Funding Release Request, in form and substance reasonably satisfactory to Agent,
from Company to Agent, requesting that funds on deposit in the Funding Account be released to Company following the satisfaction of the
conditions precedent contained in Sections 2.5.

 

(gg)
“GAAP” means generally accepted accounting principles in the United States of America as in effect from time to time.

 

(hh)
“Indebtedness” means, with respect to any Person at any date, without duplication, (a) all indebtedness of such Person
for borrowed money, (b) all obligations of such Person for the deferred purchase price of property or services (but excluding trade payables
incurred in the ordinary course of business), (c) all obligations of such Person evidenced by notes, bonds, debentures or other similar
instruments, (d) all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property
acquired by such Person (even though the rights and remedies of the seller or the purchaser under such agreement in the event of default
are limited to repossession or sale of such property), (e) all capital lease obligations of such Person, (f) all obligations of such
Person, contingent or otherwise, as an account party or applicant under acceptance, letter of credit, surety bond or similar facilities,
(g) all obligations of such Person, contingent or otherwise, to purchase, redeem, retire or otherwise acquire for value any capital stock
of such Person, (h) all obligations for any earn-out consideration, (i) the liquidation value of preferred capital stock of such Person,
(j) all guarantee obligations of such Person in respect of obligations of the kind referred to in clauses (a) through (i) above, (k)
all obligations of the kind referred to in clauses (a) through (i) above secured by (or for which the holder of such obligation has an
existing right, contingent or otherwise, to be secured by) any lien on property (including, without limitation, accounts and contract
rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation and all obligations
of such Person in respect of hedge agreements; and (l) all Contingent Obligations in respect to indebtedness or obligations of any Person
of the kind referred to in clauses (a)-(k) above. The Indebtedness of any Person shall include, without duplication, the Indebtedness
of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor
as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such
Indebtedness expressly provide that such Person is not liable therefor.

 

    	-4-

    	 

    

 

(ii)
“Individual Guarantor” means each of Philip Falcone, Kenneth Orr, FFO 1 2021 Irrevocable Trust, FFO 2 2021 Irrevocable
Trust and KORR Value LP.

 

(jj)
“Individual Guaranty Agreement” means the Limited Guaranty Agreement, dated as of the Closing Date, made by each Individual
Guarantor in favor of the Agent for the benefit of the Purchasers, in form and substance reasonably satisfactory to the Agent.

 

(kk)
“Individual Pledge Agreement” means the Limited Guarantor Pledge Agreement, made by each Individual Guarantor in favor
of the Agent for the benefit of the Purchasers, in form and substance reasonably satisfactory to the Agent.

 

(ll)
“Investment” means any investment (including, without limitation, any loan or advance) in or to any Person, whether
payment therefor is made in cash or capital stock or other equity interests or otherwise, and whether such Investment is by acquisition
of capital stock or other equity interests or Indebtedness, or by loan, advance, transfer of property out of the ordinary course of business,
capital contribution, equity or profit sharing interest, extension of credit on terms other than those normal in the ordinary course
of business or otherwise.

 

(mm)
“Joint Sales Agreement” shall mean an agreement for the sale of commercial or advertising time or any similar arrangement
pursuant to which a Person (other than the Person holding the FCC License for the applicable television broadcast station or an Affiliate
of such Person) obtains the right to (i) sell at least a majority of the time for commercial spot announcements, and/or resell to advertisers
such time on, (ii) provide the sales staff for the sale of the advertising time or the collection of accounts receivable with respect
to commercial advertisements broadcast on, (iii) set the rates for advertising on and/or (iv) provide the advertising material for broadcast
on, such television broadcast station.

 

(nn)
“Liens” or “liens” means a lien, mortgage, charge pledge, security interest, encumbrance, right
of first refusal, preemptive right or other restriction, or other clouds on title.

 

(oo)
“Liabilities” means all direct or indirect liabilities, Indebtedness and obligations of any kind of Company to the
Agent and/or the Purchasers, howsoever created, arising or evidenced, whether now existing or hereafter arising (including those acquired
by assignment), absolute or contingent, due or to become due, primary or secondary, joint or several, whether existing or arising through
discount, overdraft, purchase, direct loan, participation, operation of law, or otherwise, including, but not limited to, pursuant to
the Notes, this Agreement and/or any of the other Transaction Documents, all accrued but unpaid interest on the Notes, the principal,
any letter of credit, any standby letter of credit, and/or outside attorneys’ and paralegals’ fees or charges relating to
the preparation of the Transaction Documents and the enforcement of the Agent’s and/or the Purchasers’ rights, remedies and
powers under this Agreement, the Notes, the Warrants and/or the other Transaction Documents.

 

    	-5-

    	 

    

 

(pp)
“License” shall mean any license, authorization, permit, consent, franchise, ordinance, registration, certificate,
agreement or other right filed with, granted by, or entered into by a federal, state or local governmental authority which permits or
authorizes the acquisition, construction or operation of a television station or any part of a television station or which is required
for the acquisition, ownership or operation of any Station, including, without limitation, the FCC Licenses.

 

(qq)
“License Sub” shall mean each Subsidiary of the Company which has no assets other than FCC Licenses and no liabilities.

 

(rr)
“Local Marketing Agreement” shall mean a local marketing arrangement, time brokerage agreement, management agreement
or similar arrangement pursuant to which a Person (other than the Person holding the FCC License for the applicable television broadcast
station or an Affiliate of such Person) obtains the right, subject to customary preemption rights and other limitations, to exhibit programming
and sell advertising time during more than fifteen percent (15%) of the air time per week of such television broadcast station.

 

(ss)
“Material Adverse Effect” means a material adverse effect on (a) the business, assets, property, operations, or condition
(financial or otherwise) of any Obligor, (b) the validity or enforceability of this Agreement or any of the other Transaction Documents,
(c) the rights or remedies of the Agent or any Purchaser hereunder or thereunder, or (d) the ability of any Obligor to perform its obligations
under any Transaction Document.

 

(tt)
“Note” means all of the Original Issue Discount Senior Secured Convertible Promissory Notes due on the third anniversary
of the Closing Date that are owned by the Purchasers, which, subject to the terms and conditions set forth in this Agreement, shall be
purchased from the Company pursuant to this Agreement, and any and all Note(s) issued in exchange, transfer or replacement of the Note(s),
in each case, in form and substance satisfactory to the Agent.

 

(uu)
“NRJ Acquisition Agreement” means
that certain Asset Purchase Agreement, dated as of the Closing Date, by and among Sovryn Holdings, Inc., as buyer, and NRJ TV III CA
Opco, LLC and NRJ TV III CA License Co., LLC, as sellers.

 

(vv)
“Obligor” means the Company, each of its Subsidiaries and each Individual Guarantor.

 

    	-6-

    	 

    

 

(ww)
“Operating Agreement” shall mean any agreement in respect of a Sharing Arrangement, network affiliation agreement,
programming agreement, franchise agreement, lease or other agreement of the Company or any of its Subsidiaries relating to the operation
of a Station.

 

(xx)
“Ownership Reports” shall mean, with respect to any Station, the reports
and certifications filed with the FCC pursuant to 47 C.F.R. §73.3615, or any comparable reports filed pursuant to any successor
regulation thereto.

 

(yy)
“Permitted Indebtedness” means (i) the indebtedness evidenced by the Notes, (ii) any indebtedness of the Company outstanding
as of the date of this Agreement that is listed on Schedule 3.1(n), and (iii) purchase money indebtedness incurred in connection
with the acquisition of capital assets and lease obligations with respect to newly acquired or leased assets in the ordinary course of
business in an aggregate principal amount outstanding at any time not to exceed $1,000,000.

 

(zz)
“Permitted Lien” means the individual and collective reference to the following: (a) Liens for taxes, assessments
and other governmental charges or levies not yet due or Liens for taxes, assessments and other governmental charges or levies being contested
in good faith and by appropriate proceedings for which adequate reserves (in the good faith judgment of the management of the Company)
have been established in accordance with GAAP; (b) Liens imposed by law which were incurred in the ordinary course of the Company’s
business, such as carriers’, warehousemen’s and mechanics’ Liens, statutory landlords’ Liens, and other similar
Liens arising in the ordinary course of the Company’s business, and which (x) do not individually or in the aggregate materially
detract from the value of such property or assets or materially impair the use thereof in the operation of the business of the Company
and its consolidated Subsidiaries or (y) are being contested in good faith by appropriate proceedings, which proceedings have the effect
of preventing for the foreseeable future the forfeiture or sale of the property or asset subject to such Lien; (c) Liens incurred in
connection with Permitted Indebtedness permitted under clause (iii) of the definition thereof; provided that such Liens (i) attach
only to the property so acquired and (ii) secure only the Indebtedness that was incurred to acquire such property; (d) pledges and deposits
made in the ordinary course of business in compliance with workers’ compensation, unemployment insurance and other social security
laws or regulations; (e) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal
bonds, performance bonds and other obligations of a like nature that are not past due, in each case in the ordinary course of business,
but excluding any contract for the payment of money; and (f) any Liens in favor of the Agent.

 

(aaa)
“Person” means any individual, sole proprietorship, partnership, joint venture, trust, unincorporated organization,
association, corporation, institution, entity, party or government (whether national, federal, state, county, city, municipal or otherwise
including, without limitation, any instrumentality, division, agency, body or department thereof).

 

(bbb)
“Principal Market” means the principal Trading Market on which the Common Stock is listed or quoted for trading on
the date in question.

 

    	-7-

    	 

    

 

(ccc)
“Proceeding” means an action, claim,
suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition),
whether commenced or threatened. 

 

(ddd)
“Purchase Price” shall have the
meaning as set forth on Schedule 1 next to the heading “Purchase Price,” in United States Dollars.

 

(eee)
“Registration Rights Agreement” means the Registration Rights Agreement, dated as of the Closing Date, by and between
the Company and the Purchasers as hereinafter amended and/or supplemented altogether with all exhibits, schedules and annexes to such
Registration Rights Agreement, in each case, in form and substance satisfactory to the Agent.

 

(fff)
“Registration Statement” means
a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale of the Conversion
Shares, the Warrant Shares and the Commitment Conversion Shares, each as provided for in the Registration Rights Agreement.

 

(ggg)
“SEC” or “Commission” means the United States Securities and Exchange Commission.

 

(hhh)
“Securities” means the Notes, the Warrants and the Commitment Shares
purchased pursuant to this Agreement, all Conversion Shares, all Warrant Shares, all Commitment Conversion Shares and any securities
of the Company issued to the Purchasers in replacement, substitution and/or in connection with any exchange, conversion and/or any other
transaction involving all or any of such securities of the Company.

 

(iii)
“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

(jjj)
“Security Agreement” means the Security Agreement, dated on or about the date hereof, by and among the Company, the
Subsidiaries of the Company, and the Agent, as hereinafter amended and/or supplemented altogether with all exhibits, schedules and annexes
to such Security Agreement, pursuant to which the Liabilities are secured by the Collateral, in form and substance satisfactory to the
Agent.

 

(kkk)
“Series F Preferred Stock” means the Company’s Series F convertible preferred stock, par value $0.001 per share.

 

(lll)
“Shared Services Agreement” shall mean a shared services arrangement or other similar arrangement pursuant to which
two Persons (who are not Affiliates of each other) owning separate television broadcast stations agree to share the costs of certain
services and procurements which they individually require in connection with the ownership and operation of one television broadcast
station, whether through the form of joint or cooperative buying arrangements or the performance of certain functions relating to the
operation of one television broadcast station by employees of the owner and operator of the other television broadcast station, including,
but not limited to, the co-location of the studio, non-managerial administrative and/or master control and technical facilities of such
television broadcast station and/or the sharing of maintenance, security and other services relating to such facilities.

 

    	-8-

    	 

    

 

(mmm)
“Shareholder Approval” shall mean the approval of an amendment to the Company’s Articles of Incorporation to
increase the number of shares of Common Stock authorized thereunder from 500,000,000 to 6,000,000,000 by a majority of the votes entitled
to be cast thereon, whether presented at a special or annual meeting of shareholders of the Company and the subsequent filing of such
amendment with the Secretary of State of the State of Nevada.

 

(nnn)
“Sharing Arrangement” shall mean any Station Servicing Arrangement or Station Sharing Arrangement.

 

(ooo)
“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act
(but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

 

(ppp)
“SMRH” means Sheppard, Mullin,
Richter & Hampton LLP, with offices located at 30 Rockefeller Plaza, 39th Floor, New York, New York 10112.

 

(qqq)
“Station” shall mean, collectively (a) each of the television stations to be acquired pursuant to the NRJ Acquisition
Agreement, and (b) any other television station acquired after the Closing Date by the Company or any of its Subsidiaries in accordance
with the terms of this Agreement and the other Transaction Documents.

 

(rrr)
“Station Servicing Arrangement” shall mean any arrangement or transaction evidenced by any Joint Sales Agreement,
Local Marketing Agreement, Shared Services Agreement or similar agreement or instrument under which the Company or any of its Subsidiaries
provides services or obtains the right to provide programming to, or sells advertising availabilities on, a television broadcast station
of another Person (other than the Company or any of its Subsidiaries).

 

(sss)
“Station Sharing Arrangement” shall mean any arrangement or transaction evidenced by any Joint Sales Agreement, Local
Marketing Agreement, Shared Services Agreement or similar agreement or instrument under which a Person, other than the Company or any
of its Subsidiaries, provides services or obtains the right to provide programming to, or sells advertising availabilities on, a Station.

 

(ttt)
“Subsequent Equity Financing”
shall have the meaning ascribed to such term in Section 4.20.

 

(uuu)
“Subsequent Equity Financing Closing”
shall have the meaning ascribed to such term in Section 4.20.

 

(vvv)
“Subsequent Equity Financing Deadline Date”
shall have the meaning ascribed to such term in Section 4.20.

 

    	-9-

    	 

    

 

(www)
“Subsidiary” means, with respect to any Person, a corporation, partnership, limited liability company or other entity
of which shares of stock or other ownership interests having ordinary voting power (other than stock or such other ownership interests
having such power only by reason of the happening of a contingency) to elect a majority of the board of directors or other managers of
such corporation, partnership or other entity are at the time owned, or the management of which is otherwise controlled, directly or
indirectly through one or more intermediaries, or both, by such Person. All of the Company’s Subsidiaries are set forth on Schedule
3.1(a) hereto.

 

(xxx)
“Subsidiary Guaranty Agreement” means each Guaranty Agreement, between a Subsidiary and the Agent, as
amended, restated, supplemented or otherwise modified from time to time, in form and substance satisfactory to the Agent.

 

(yyy)
“Trading Day” means a day on which the principal Trading Market is open for trading.

 

(zzz)
“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for
trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange, any market or quotation service of the OTC Markets Group (including the OTCQX, the OTCQB, the Pink Open
Market or any successors to any of the foregoing).

 

(aaaa)
“Transaction Documents” means, collectively, this Agreement, the Notes, the Registration Rights Agreement, the Warrants,
the Security Agreement, each Subsidiary Guaranty Agreement, the Individual Guaranty Agreement, the Individual Pledge Agreement and all
financing statements (or comparable documents now or hereafter filed in accordance with the UCC or other comparable or similar laws,
rules or regulations) in favor of the Agent perfecting all Liens the Agent has on the Collateral (which security interests and Liens
of the Agent shall be senior to all Indebtedness of the Company and its Subsidiaries), any Control Agreement, and such other documents,
instruments, certificates, supplements, amendments, exhibits and schedules required and/or attached pursuant to this Agreement and/or
any of the above documents, and/or any other document and/or instrument related to the above agreements, documents and/or instruments,
and the transactions hereunder and/or thereunder and/or any other agreement, documents or instruments required or contemplated hereunder
or thereunder, whether now existing or at any time hereafter arising.

 

(bbbb)
“Transfer Agent” means Pacific Stock Transfer Co., the current transfer agent of the Company, with a mailing address
of 6725 Via Austi Parkway, Suite 300, Las Vegas, NV 89119 and a phone number of 800-785-7782,
and any successor transfer agent of the Company.

 

(cccc)
“UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York; provided,
however, that, in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, priority,
or remedies with respect to the Agent’s Liens on any Collateral is governed by the Uniform Commercial Code as enacted and in effect
in a jurisdiction other than the State of New York, the term “UCC” shall mean the Uniform Commercial code as enacted
and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority,
or remedies.

 

    	-10-

    	 

    

 

(dddd)
“Underlying Shares” means all Conversion Shares, all Warrant Shares and all Commitment Conversion Shares.

 

(eeee)
“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the
nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
in the “Pink Sheets” published by OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

(ffff)
“Warrant Shares” has the meaning assigned to such term in the Warrants.

 

(gggg)
“Warrants” means those certain Common Stock Purchase Warrants, issued by the Company to the Purchasers on the Closing
Date and any and all Warrant(s) issued in exchange, transfer or replacement of the Warrant(s), in each case, in form and substance satisfactory
to the Agent.

 

1.2
Other Definitional Provisions.

 

(a)
Use of Defined Terms. Unless otherwise specified therein, all terms defined in this Agreement shall have the defined meanings
when used in the other Transaction Documents or any certificate or other document made or delivered pursuant hereto or thereto.

 

(b)
Accounting Terms. As used herein and in the other Transaction Documents, and any certificate or other document made or delivered
pursuant hereto or thereto, accounting terms relating to the Company not defined in Section 1.1 and accounting terms partly defined
in Section 1.1, to the extent not defined, shall have the respective meanings given to them under GAAP (provided that all
terms of an accounting or financial nature used herein shall be construed, and all computations of amounts referred to herein shall be
made without giving effect to (i) any election under Accounting Standards Codification 825-10-25 (previously referred to as Statement
of Financial Accounting Standards 159) (or any other Accounting Standards Codification or Financial Accounting Standard having a similar
result or effect) to value any Indebtedness or other liabilities of the Company at “fair value”, as defined therein, and
(ii) any treatment of Indebtedness in respect of convertible debt instruments under Accounting Standards Codification 470-20 (or any
other Accounting Standards Codification or Financial Accounting Standard having a similar result or effect) to value any such Indebtedness
in a reduced or bifurcated manner as described therein, and such Indebtedness shall at all times be valued at the full stated principal
amount thereof).

 

    	-11-

    	 

    

 

(c)
Construction. The words “hereof”, “herein” and “hereunder” and words
of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement,
and section, schedule and exhibit references are to this Agreement unless otherwise specified. The meanings given to terms defined herein
shall be equally applicable to both the singular and plural forms of such terms.

 

(d)
UCC Terms. Terms used in this Agreement that are defined in the UCC shall, unless the context indicates otherwise or are otherwise
defined in this Agreement, have the meanings provided for by the UCC.

 

ARTICLE
2

PURCHASE
AND SALE

 

2.1
Closing. On the Closing Date, time being of the essence, subject to the occurrence of the conditions set forth in Section 2.3,
upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and each Purchaser severally, but not jointly
or jointly and severally, agrees to purchase, the Securities in such amounts as indicated next to its name on Schedule
1 hereto. Each Purchaser shall deliver, via wire transfer, immediately available funds equal to the Purchase Price for its
Securities as set forth in Section 2.5 hereof, and the Company shall deliver to each Purchaser the Note, the Warrant and the Commitment
Shares specified opposite its name on Schedule 1 on the Closing Date, and the Company and the Purchasers shall deliver the other
items set forth in Section 2.2 deliverable on the Closing Date. Upon satisfaction of the covenants and conditions set forth in
Sections 2.2 and 2.3, the closing shall occur at the offices of SMRH or such other location as the parties shall mutually agree.

 

2.2
Deliveries.

 

(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to the Agent and the Purchasers the following:

 

(i)
this Agreement duly executed by the Company;

 

(ii)
a Security Agreement providing the Agent (for the benefit of the Purchasers) with a lien on all of the assets of the Company and its
Subsidiaries, duly executed by the Company and its Subsidiaries;

 

(iii)
a Note registered in the name of each Purchaser with such principal amount as set forth on Schedule 1, duly executed by the Company;

 

    	-12-

    	 

    

 

(iv)
the Commitment Shares, registered in the name of each Purchaser as set forth on Schedule 1;

 

(v)
a Warrant, registered in the name of each Purchaser as set forth on Schedule 1, duly executed by the Company;

(vi)
the Registration Rights Agreement duly executed by the Company;

 

(vii)
the Individual Guaranty Agreement, duly executed by the Individual Guarantors;

 

(viii)
the Individual Pledge Agreement, duly executed by the Individual Guarantors;

 

(ix)
UCC financing statements with respect to each Obligor;

 

(x)
a certificate, in the form acceptable to the Purchasers and their counsel, executed by the secretary of the Company dated as of the Closing
Date, as to (i) the resolutions as adopted by the Company’s board of directors relating to the transactions contemplated by this
Agreement in a form acceptable to the Purchasers, (ii) Certificate of Incorporation or other similar organizational document of the Company,
(iii) the Bylaws or other similar organizational document of the Company, (iv) the NRJ Acquisition Agreement and each of the documents
executed in connection therewith (along with a certification that such documents are in full force and effect), and (v) the Exchange
Agreement, each as in effect on the Closing Date;

 

(xi)
a certificate for each Subsidiary of the Company, in the form acceptable to the Purchasers and their counsel, executed by the secretary
of such Subsidiary dated as of the Closing Date, as to (i) the resolutions as adopted by the Subsidiary’s board of directors or
other governing body relating to the transactions contemplated by this Agreement in a form acceptable to the Purchasers, (ii) Certificate
of Incorporation or other similar organizational document of such Subsidiary, and (iii) the Bylaws or other similar organizational document
of such Subsidiary, each as in effect on the Closing Date;

 

(xiii)
a certificate, duly executed by the Chief Executive Officer of the Company, dated as of the Closing Date, confirming compliance with
Section 2.3(b)(i) and (ii) below and as to such other matters as may be reasonably requested by the Purchasers and their counsel
in the form acceptable to the Purchasers;

 

(xiii)
certificates evidencing the good standing of the Company and each Company Subsidiary in such entity’s jurisdiction of incorporation
issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within five (5) days of the Closing
Date;

 

(xiv)
an opinion of counsel to the Company and its Subsidiaries, in such form as reasonably acceptable to the Purchasers;

 

    	-13-

    	 

    

 

(xv)
a Subsidiary Guaranty Agreement for each Subsidiary
of the Company;

 

(xvi)
the Closing Fee (payable in cash or by set-off from the Purchase Price), unless deferred by the Purchasers; and

 

(xvii)
such other documents, instruments, opinions or certificates relating to the transactions contemplated by this Agreement as the Purchasers
or their counsel may reasonably request.

 

(b)
On or prior to the Closing, each Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i)
this Agreement duly executed by such Purchaser;

 

(ii)
the portion of the Purchase Price specified opposite its name on Schedule 1 hereto, by wire transfer; provided, that it
is understood and agreed that the Purchase Price shall be delivered as set forth in Section 2.5 hereof;

 

(iii)
the Security Agreement duly executed by such Purchaser and the Agent; and

 

(iv)
the Registration Rights Agreement duly executed by such Purchaser.

 

2.3
Conditions to Purchase the Securities. Subject to the terms and conditions of this Agreement, on the Closing Date, each Purchaser,
severally, but not jointly or jointly and severally, will purchase from the Company the Securities in the amounts and for the Purchase
Price as set forth opposite its name on Schedule 1, provided the following:

 

(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)
all obligations, covenants and agreements of the Purchasers required to be performed at or prior to the Closing Date shall have been
performed;

 

(iii)
the delivery by the Purchasers of the items set forth in Section 2.2(b) of this Agreement;

 

(iv)
there shall have been no Material Adverse Effect with respect to the Company and its Subsidiaries, taken as a whole, since the Balance
Sheet Date; and

 

(v)
no statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or other federal, state, local or other governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents.

 

    	-14-

    	 

    

 

(b)
The obligations of each Purchaser hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the date of the Closing of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);

 

(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing shall have been performed
in all material respects;

 

(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iv)
there shall have been no Material Adverse Effect with respect to the Company and its Subsidiaries, taken as a whole, since the Balance
Sheet Date;

 

(v)
the Company shall have obtained all governmental, regulatory and third party consents and approvals, if any, necessary for the entry
into the Transaction Documents and the sale of the Securities;

 

(vi)
the NRJ Acquisition Agreement, the Exchange Agreement and each of the documents required to be executed in connection therewith shall
have been executed and delivered by each of the parties thereto; and

 

(vii)
no statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or other federal, state, local or other governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents.

 

2.4
Purchase Price and Payment of the Purchase Price for the Securities. The Purchase Price for the Securities to be purchased by
each Purchaser at the Closing shall be as set forth opposite its name on Schedule 1 and shall be paid at the Closing by the Purchasers
by wire transfer of immediately available funds against delivery of the Securities; provided, that it is understood and agreed
that (a) $2,000,000 of the Purchase Price shall be delivered to the Company on the Closing Date for application to the Deposit and the
Option Fee (each as defined in the NRJ Acquisition Agreement), and (b) $14,500,000 shall be funded to the Funding Account for release
(i) to the Company to fund acquisitions by the Company and/or its Subsidiaries that are approved by the Purchasers and (ii) to the Purchasers
to pay original issue discount on the Notes, the Closing Fee and Purchaser’s Expenses incurred on or prior to the Closing Date
(which release, in the case of this clause (ii) shall not occur later than the NRJ Acquisition Closing Date and shall not be subject
to the release procedures described above). Notwithstanding the foregoing, the entire amount of the Purchase Price shall be deemed to
have been delivered to the Company on the Closing Date (and interest shall accrue on the full amount of the Purchase Price commencing
on the Closing Date).

 

    	-15-

    	 

    

 

2.5
Funding Account.

 

(a)
Releases from Funding Account. The obligation of the Purchasers to direct the Agent to release any funds from the Funding Account
on any proposed Funding Release Date (each, a “Funding Release”) is subject to the fulfillment, in a manner reasonably
satisfactory to the Purchasers, of each of the following conditions precedent:

 

(i)
Funding Release Request. The Purchasers shall have received at least 5 Trading Days prior to the proposed Funding Release Date,
a fully-completed Funding Release Request (together with all attachments thereto), executed by the Company, together with such other
documents and certificates that the Agent or the Purchasers may request.

 

(ii)
Specific Conditions. In the case of any Funding Release being made (A) as a result of the consummation of the acquisition contemplated
by the NRJ Acquisition Agreement, the Agent shall have received evidence that the NRJ Acquisition Closing Date has occurred in accordance
with the terms of the NRJ Acquisition Agreement and applicable law (without any amendment or waiver of the terms of the NRJ Acquisition
Agreement (including, without limitation, any waiver of the conditions precedent to closing)) or (B) for any other reason, the Agent
and the Purchasers shall have such other information and documents as they have requested, which shall include, for the avoidance of
doubt, evidence that the Purchasers have consented to the proposed use of proceeds on such Funding Release Date. For the avoidance of
doubt, it is understood and agreed that the maximum amount of funds to be released on the Funding Release Date described in clause (A)
above shall not exceed $8,000,000, and the maximum amount of funds to be released on any other Funding Release Date shall be the amount
approved by the Purchasers for such Funding Release Date.

 

(iii)
No Default, Etc. No Default, Event of Default or event that has had or could reasonably be expected to have, a Material Adverse
Event, shall have occurred and be continuing on the Funding Release Date, or would result from the making of the Funding Release.

 

(iv)
Representations and Warranties. All of the representations and warranties contained in this Agreement and in each other Transaction
Document and certificate delivered to Agent or any Purchaser shall be true and correct in all material respects (without duplication
of materiality qualifiers contained therein) on and as of the Funding Release Date with the same force and effect as if such representations
and warranties had been made on and as of such date (other than any representation or warranty that specifically refers to an earlier
date, in which case such representation or warranty was true and correct in all material respects (without duplication of materiality
qualifiers contained therein) as of such earlier date).

 

    	-16-

    	 

    

 

(v)
Additional Documentation. Agent and Purchasers shall have received such additional agreements, certificates, documents, approvals,
or opinions as Agent, Purchasers and/or their legal counsel may reasonably request.

 

(b)
Grant of Security Interest in Funding Account. As security for the due and punctual payment in full of the Liabilities, the Company
hereby assigns to the Agent and grants to the Agent, a first and prior Lien upon all of its rights, title and interest in and to the
Funding Account, all cash, documents, instruments and securities from time to time held therein, and all rights pertaining to investments
of funds in the Funding Account and all products and proceeds of any of the foregoing. All cash, documents, instruments and securities
from time to time on deposit in the Funding Account, and all rights pertaining to investments of funds in the Funding Account shall immediately
and without any need for any further action on the part of any Person become subject to the Lien set forth in this Section 2.5,
be deemed Collateral for all purposes under the Transaction Documents and be subject to the provisions of the Transaction Documents.
The Funding Account shall be under the sole dominion and control of the Agent.

 

(c)
Funding Account Generally.

 

(i)
Upon the occurrence and during the continuance of an Event of Default under this Agreement, the Agent may, in addition to any and all
other rights and remedies available to the Agent and the Purchasers hereunder and under the other Transaction Documents, apply any sums
then present in the Funding Account to the payment of the Indebtedness in any order in its sole discretion.

 

(ii)
Any interest on the amounts on deposit in the Funding Account shall be added to or become a part of the funds on deposit in such Funding
Account for all purposes of the Transaction Documents. The Company shall be responsible for payment of any federal, state or local income
or other tax applicable to such interest.

 

(iii)
The Company shall not further pledge, assign or grant any security interest in the Funding Account or the income or proceeds thereof
or permit any Lien or encumbrance to attach thereto, or any levy to be made thereon, or any UCC financing statements, except those naming
Agent as the secured party, to be filed with respect thereto.

 

(iv)
Neither the Agent nor any Purchaser shall be liable for any loss sustained on any funds on deposit in the Funding Account.

 

(v)
Any amount remaining in the Funding Account after all Liabilities have been indefeasibly paid in full, shall be returned to the Company.

 

    	-17-

    	 

    

 

ARTICLE
3

REPRESENTATIONS AND WARRANTIES; OTHER ITEMS

 

3.1
Representation and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules (but in no event shall qualify any indemnity obligation of the Company hereunder),
the Company represents and warrants to the Agent and the Purchasers on the Closing Date and on each date on which the representations
and warranties are required to be made or remade (unless as of a specific date set forth below) as follows:

 

(a)
Subsidiaries. All of the direct and indirect subsidiaries of the Company and the locations thereof are set forth on Schedule
3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and
clear of any Liens, and all of the issued and outstanding shares of capital stock or other interests of each Subsidiary are validly issued
and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. Schedule 3.1(a)
sets forth, as of the Closing Date, the jurisdiction of organization and the location of the Company’s and its subsidiaries’
executive offices and other places of business.

 

(b)
Organization, Etc. The Company and each of the Subsidiaries is duly organized, validly existing and in good standing under the
laws of the state of their respective organization and are duly qualified and in good standing or has applied for qualification as a
foreign corporation authorized to do business in each jurisdiction where, because of the nature of its activities or properties, such
qualification is required except where the failure to be so qualified would not reasonably be expected to have a Material Adverse Effect.

 

(c)
Authorization: No Conflict. The execution, delivery and performance of the Transaction Documents and the transactions contemplated
thereby by the Company and its Subsidiaries (including, but not limited to, (x) the sale and issuance of the Securities for the Purchase
Price, (y) subject to the receipt of Shareholder Approval, the reservation for issuance of the Conversion Shares required to be reserved
pursuant to the terms of the Notes, the reservation for issuance of the Warrant Shares required to be reserved pursuant to the terms
of the Warrants, and the reservation for issuance of the Commitment Conversion Shares required to be reserved pursuant to the terms of
the Certificate of Designation regarding the Commitment Shares, and (z) subject to the receipt of Shareholder Approval, the issuance
of the Warrant Shares, the Conversion Shares and the Commitment Conversion Shares) (i) are within the corporate powers of the Company
and its Subsidiaries, (ii) have been duly authorized by all necessary action by or on behalf of the Company and its Subsidiaries (and/or
their respective stockholders to the extent required by law), (iii) have received all necessary and/or required governmental, regulatory
and other approvals and consents (if any shall be required), (iv) do not and shall not contravene or conflict in any material respect
with any provision of, or require any consents under (1) any law, rule, regulation or ordinance, (2) the Company’s or any Subsidiary’s
organizational documents; and/or (3) any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt
or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company
or any Subsidiary is bound or affected, and (v) other than the Liens granted to the Agent for the benefit of the Purchasers pursuant
to the Transaction Documents, do not result in, or require, the creation or imposition of any Lien and/or encumbrance on any of the Company’s
or any Subsidiary’s properties or revenues pursuant to any law, rule, regulation or ordinance or otherwise.

 

    	-18-

    	 

    

 

(d)
Validity and Binding Nature. The Transaction Documents to which the Company or any of its Subsidiaries is a party are the legal,
valid and binding obligations of the Company and/or such Subsidiary, enforceable against the Company and/or such Subsidiary in accordance
with their respective terms, except as enforceability may be limited by bankruptcy, insolvency, reorganization and other similar laws
of general application affecting the rights and remedies of creditors and by general equitable principles (whether enforcement is sought
by proceedings in equity or at law).

 

(e)
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for Permitted Liens. Any real property and facilities held under lease by the Company
and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are
in compliance.

 

(f)
Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation
of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is
in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or
any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree
or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance
or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to securities,
corporate law, taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters,
except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(g)
Taxes. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all
foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount
claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis
for any such claim.

 

    	-19-

    	 

    

 

(h)
Licenses and Permits. The Company and each of its Subsidiaries possesses all certificates,
authorizations, consents, approvals, orders, Licenses and permits issued by the appropriate federal, state or foreign regulatory authorities
(collectively, the “Permits”), necessary to conduct its business as now
conducted. All of such Permits are valid and in full force and effect. There is no pending or, to the Company’s knowledge, threatened
action, suit, proceeding or investigation that individually or in the aggregate would reasonably be expected to lead to the revocation,
modification, termination, suspension or any other impairment of the rights of the holder of any such Permit.

 

(i)
Investment Company. The Company is not (i) an “investment company” or a company “controlled”, whether
directly or indirectly, by an “investment company”, within the meaning of the Investment Company Act of 1940, as amended;
or (ii) engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing
or carrying margin stock (within the meaning of Regulation U of the Board of Governors of the Federal Reserve System).

 

(j)
Absence of Defaults and Conflicts. Neither the Company nor any of its Subsidiaries is (i)
in violation of its charter, by-laws or similar incorporation or organizational documents
or (ii) in violation or default in the performance or observance of any material obligation, agreement, covenant or condition contained
in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which
the Company or such Subsidiary is a party or by which it may be bound, or to which any of the property or assets of the Company is subject
(collectively, “Agreements and Instruments”). The execution, delivery
and performance of this Agreement and the consummation of the transactions contemplated in this Agreement and the other Transaction Documents,
and compliance by the Company and its Subsidiaries with its obligations under this Agreement and the other Transaction Documents, do
not and will not, whether with or without the giving of notice or passage of time or both, (w) conflict with or result in a breach of
any of the terms and provisions of, or constitute a default or Repayment Event (as defined below) under, (x) result in the creation or
imposition of any lien, charge or encumbrance (other than Permitted Liens) upon any property or assets of the Company or any Subsidiary
pursuant to, the Agreements and Instruments, (y) result in any violation of the provisions of the charter, by-laws or
similar organizational documents of the Company or any Subsidiary, or (z) result in any applicable law, statute, rule, regulation, judgment,
order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Company,
any of its Subsidiaries or any of their respective assets, properties or operations, except in the case of this clause (z) for such conflicts,
violations, breaches or defaults which would not reasonably be expected to result in a Material Adverse Effect. As used herein, a “Repayment
Event” means any event or condition which gives the holder of any note, debenture or
other evidence of indebtedness that is material to the operations or financial results of the Company (or any person acting on such holder’s
behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company.

 

    	-20-

    	 

    

 

(k)
Foreign Corrupt Practices Act. Neither the Company nor any of its Subsidiaries, nor, to
the Company’s knowledge, any of its affiliates, directors, officers, employees, agents or other person acting on behalf of the
Company or any of its Subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a material violation
by such person of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the “FCPA”),
including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance
of an offer, payment, promise to pay or authorization of the payment of money, or other property, gift, promise to give, or authorization
of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political
party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and its Subsidiaries,
and, to the Company’s knowledge, its affiliates have conducted their businesses in material compliance with the FCPA and have instituted
and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance
therewith.

 

(l)
Rule 506(d) Bad Actor Disqualification Representations and Covenants.

 

(i)
No Disqualification Events. Neither the Company, nor any of its predecessors, affiliates, any manager, executive officer, other
officer of the Company or any Subsidiary participating in the offering, any beneficial owner (as that term is defined in Rule 13d-3 under
the Exchange Act) of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power,
nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity as of the
date of this Agreement and on the Closing Date (each, a “Company Covered Person” and, together, “Company
Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine (A) the identity of each person that is a Company Covered Person; and
(B) whether any Company Covered Person is subject to a Disqualification Event. The Company has complied with its disclosure obligations
under Rule 506(e).

 

(ii)
Other Covered Persons. The Company is not aware of any person (other than any Company Covered Person) who has been or will be
paid (directly or indirectly) remuneration in connection with the purchase and sale of the Notes, the Warrants and the Commitment Shares
who is subject to a Disqualification Event (each, an “Other Covered Person”).

 

(iii)
Reasonable Notification Procedures. With respect to each Company Covered Person, the Company has established procedures reasonably
designed to ensure that the Company receives notice from each such Company Covered Person of (A) any Disqualification Event relating
to that Company Covered Person, and (B) any event that would, with the passage of time, become a Disqualification Event relating to that
Company Covered Person; in each case occurring up to and including the Closing Date.

 

    	-21-

    	 

    

 

(iv)
Notice of Disqualification Events. The Company will notify each Purchaser immediately in writing upon becoming aware of (A) any
Disqualification Event relating to any Company Covered Person and (B) any event that would, with the passage of time, become a Disqualification
Event relating to any Company Covered Person and/or Other Covered Person.

 

(m)
Accuracy of Information, etc. No statement or information contained in this Agreement, any other Transaction Document or any other
document, certificate or statement furnished to the Agent or any Purchaser by or on behalf of any Obligor in writing for use in connection
with the transactions contemplated by this Agreement and/or the other Transaction Documents contained, as of the date such statement,
information, document or certificate was made or furnished, as the case may be, any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements contained herein or therein, taken as a whole, not materially misleading. There
is no fact known to the Company or any of its Subsidiaries that would reasonably be expected to materially affect any Obligor that has
not been expressly disclosed herein, in the other Transaction Documents, or in any other documents, certificates and written statements
furnished to the Agent or any Purchaser for use in connection with the transactions contemplated hereby and by the other Transaction
Documents.

 

(n)
Solvency. Based on the consolidated financial condition of the Company as of the Closing
Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable
value of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing
debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute
unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking
into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements
and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive,
were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).
The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation
under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. Schedule 3.1(n)
sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company
or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither the Company nor any Subsidiary is in default with
respect to any Indebtedness.

 

    	-22-

    	 

    

 

(o)
Transactions With Affiliates and Employees. None of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from providing for the borrowing of money from or lending of money to, or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 per year, other than
for: (i) without limiting the provisions of Section 7(j) of the Note, payment of salary or consulting fees for services rendered
(so long as (i) no such amounts are paid from internally generated funds and not more than $1,000,000 of such amounts are paid from proceeds
of the issuance of the Securities (with all additional amounts being paid with proceeds of equity issuances) and (ii) such salaries and
consulting fees are on customary terms for companies of a similar size and stage of development),
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements
under any stock option plan of the Company.

 

(p)
Intellectual Property. The Company and each of its Subsidiaries has, or has rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights as described on Schedule 3.1(p) that are material to the conduct of its business (collectively, the “Intellectual
Property Rights”). Neither the Company nor any of its Subsidiaries has received a notice (written or otherwise) that any material
Intellectual Property Right has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned. Neither
the Company nor any of its Subsidiaries has received, since the Balance Sheet Date, a written notice of a claim or otherwise has any
knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as would not have or reasonably
be expected to have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable
and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and each of its Subsidiaries
has taken commercially reasonable security measures to protect the secrecy, confidentiality and value of all of its intellectual property.

 

(q)
USA Patriot Act. The Company and each of its Subsidiaries is in compliance, in all material respects, with (i) the Trading with
the Enemy Act, as amended, and each of the foreign assets control regulations of the United States Treasury Department (31 C.F.R., Subtitle
B, Chapter V, as amended) and any other enabling legislation or executive order relating thereto, and (ii) the USA Patriot Act (Title
III of Pub. L. 107-56, signed into law on October 26, 2001) (the “Act”). No part of the proceeds of the Notes will
be used, directly or indirectly, for any payments to any governmental official or employee, political party, official of a political
party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or
obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended.

 

(r)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director,
officer, agent, joint venture employee or affiliate of the Company or any Subsidiary is currently, or in the past 5 years, has been subject
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

    	-23-

    	 

    

 

(s)
Filings, Consents and Approvals. Neither the Company nor any of its Subsidiaries is required
to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to the Registration
Rights Agreement and the declaration of effectiveness by the SEC of the Registration Statement, (ii) the notice and/or application(s)
to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion Shares, the Commitment
Conversion Shares and the Warrant Shares for trading thereon in the time and manner required thereby, (iii) the filing of Form D with
the Commission and such filings as are required to be made under applicable state securities laws and (iv) following the consummation
of the transactions contemplated by the NRJ Acquisition, the filing with the FCC of a copy of certain of the Transaction Documents as
required by Section 73.3613 of the FCC’s regulations (collectively, the “Required Approvals”).

 

(t)
Authorization; Enforcement. All corporate action on the part of the Company and its Subsidiaries, and their respective officers,
directors and stockholders necessary for the authorization, execution and delivery of the Transaction Documents and the performance of
all obligations of the Company and its Subsidiaries under the Transaction Documents and have been taken on or prior to the date hereof.
Each of the Transaction Documents has been duly executed by the Company and its Subsidiaries and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company and its Subsidiaries enforceable against the
Company and its Subsidiaries in accordance with its terms, except: (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by general
equitable principles regardless of whether such enforcement is considered in a proceeding in equity or at law, (iii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies and (iv) insofar as indemnification
and contribution provisions may be limited by applicable law.

 

(u)
Valid Issuance of Securities. Each Note has been duly authorized and, when issued and paid for in accordance with this Agreement,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and all restrictions on transfer other than
those expressly imposed by the federal securities laws and vest in the Purchasers full and sole title and power to the Note purchased
hereby by such Purchaser, free and clear of all Liens, and restrictions on transfer other than those imposed by the federal securities
laws. All Conversion Shares, when issued pursuant to conversion of the Notes, all Warrant Shares, when issued pursuant to exercise of
the Warrants, and all Commitment Conversion Shares, when issued pursuant to this Agreement, will be duly and validly issued, fully paid
and nonassessable, will be free and clear of all Liens and vest in the holder full and sole title and power to such securities. As of
the date of the receipt of Shareholder Approval, the Company has reserved from its duly authorized unissued Common Stock, (i) the Required
Minimum (as defined in the Notes), which Required Minimum shall be continuously determined by the Company to ensure that the Required
Minimum is in reserve with the Transfer Agent at all times and (ii) a sufficient number of shares of Common Stock to provide for the
issuance of the Warrant Shares upon the exercise of the Warrants, which number shall be continuously determined by the Company to ensure
that such number is in reserve with the Transfer Agent at all times.

 

    	-24-

    	 

    

 

(v)
Offering. The offer and sale of the Notes, the Warrants, the Commitment Shares, the Conversion Shares and the Warrant Shares,
when issued pursuant to this Agreement (or the Notes or the Warrants, as applicable), as contemplated by this Agreement, are exempt from
the registration requirements of the Securities Act, and the qualification or registration requirements of state securities laws or other
applicable blue sky laws. Neither the Company nor any authorized agent acting on its behalf will take any action hereafter that would
cause the loss of such exemptions.

 

(w)
Capitalization and Voting Rights. The capitalization of the Company is as set forth on Schedule
3.1(w), which Schedule 3.1(w) shall also
include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The
authorized capital stock of the Company and all securities of the Company issued and outstanding are set forth on Schedule 3.1(w)
as of the dates reflected therein. All of the outstanding shares of Common Stock and other securities of the Company have been duly
authorized and validly issued, and are fully paid and nonassessable. Except as set forth on Schedule
3.1(w), no Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as set forth on Schedule
3.1(w), there are no agreements or arrangements under which the Company is obligated to register the sale of any of the Company’s
securities under the Securities Act. Except as set forth on Schedule 3.1(w), no shares of Common Stock and/or other securities
of the Company are entitled to preemptive rights and there are no outstanding debt securities and no contracts, commitments, understandings,
or arrangements by which the Company is or may become bound to issue additional shares of the capital stock and/or other securities of
the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into or exchangeable for, any shares of capital stock of the Company other than those issued or granted in the
ordinary course of business pursuant to the Company’s equity incentive and/or compensatory plans or arrangements. Except for customary
transfer restrictions contained in agreements entered into by the Company to sell restricted securities and/or as set forth on Schedule
3.1(w), the Company is not a party to, and it has no knowledge of, any agreement restricting the voting or transfer of any shares
of the capital stock and/or other securities of the Company. Except as set forth on Schedule 3.1(w), the offer and sale of all
capital stock, convertible or exchangeable securities, rights, warrants, options and/or any other securities of the Company, when any
such securities of the Company were issued, complied in all material respects with all applicable federal and state securities laws,
and no current and/or prior holder of any securities of the Company has any right of rescission or damages or any “put” or
similar right with respect thereto. Except as set forth on Schedule 3.1(w), there are no securities or instruments of the Company
containing anti-dilution or similar provisions that will be triggered by the issuance and/or sale of the Securities and/or the consummation
of the transactions described herein or in any of the other Transaction Documents.

 

    	-25-

    	 

    

 

(x)
Shell Company Status; Financial Statements. The Company has been an issuer subject to Rule 144(i) under the Securities Act. The
unaudited financial statements of the Company as of September 30, 2020 is included in Schedule 3.1(x) hereto. The financial statements
of the Company included on Schedule 3.1(x) have been prepared in accordance with GAAP, except as may be otherwise specified in
such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required
by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject to normal, immaterial, year-end
audit adjustments. For purposes of this Section 3.1, September 30, 2020 is referred to as the “Balance Sheet Date”.

 

(y)
Material Changes; Undisclosed Events, Liabilities or Developments. Since the Balance Sheet Date: (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to be materially adverse to the Company or any of its Subsidiaries,
(ii) neither the Company nor any of its Subsidiaries has incurred any liabilities (contingent or otherwise) other than (A) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice, (B) liabilities not required to be reflected
in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission (if the Company is an issuer
required to file periodic reports under the Exchange Act), and (C) liabilities in respect of the NRJ Acquisition Agreement, (iii) neither
the Company nor any of its Subsidiaries has altered its method of accounting, (iv) neither the Company nor any of its Subsidiaries has
declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements
to purchase or redeem any shares of its capital stock, other than pursuant to the Exchange Agreement and (v) neither the Company nor
any of its Subsidiaries has issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock
option plans, other than pursuant to the Exchange Agreement. Except for the issuance of the Securities contemplated by this Agreement
or as set forth on Schedule 3.1(y), no event, liability, fact, circumstance, occurrence or development has occurred or exists
or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties,
operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at
the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that
this representation is made.

 

(z)
Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an “Action”) which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company, any of its Subsidiaries or any current or former director or officer of the
Company or any of its Subsidiaries. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

    	-26-

    	 

    

 

(aa)
Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any Purchaser or its respective agents or
counsel with any information that constitutes material, non-public information. The Company understands that the Purchasers may rely
on the Transaction Documents, the information included therein, including, but not limited to, the foregoing representation in purchasing
the Securities. All of the disclosure furnished by or on behalf of the Company to the Purchasers in the Transaction Documents regarding,
among other matters relating to the Company, its business and the transactions contemplated in the Transaction Documents, is true and
correct in all material respects as of the date made and does not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.
The Company acknowledges and agrees that no Purchaser has made or shall make any representations or warranties with respect to the transactions
contemplated in the Transaction Documents other than those specifically set forth in Section 3.2 hereof.

 

(bb)
No Integrated Offering. Assuming the accuracy of the representations and warranties set forth in Section 3.2, neither the
Company, nor any of its affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause the issuance and/or sale of the Securities
to be integrated with prior offerings of securities by the Company for purposes of (i) the Securities Act that would require the registration
of any such Securities and/or any other securities of the Company under the Securities Act, or that would invalidate the exemptions from
registration relied upon by the Company, or (ii) any stockholder-approval provisions of any Trading Market on which any of the securities
of the Company are listed, eligible for quotation and/or designated.

 

(cc)
Insurance. The Company and each of its Subsidiaries is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the business in which it is
engaged; neither the Company nor any of its Subsidiaries has been refused any coverage sought or applied for; and the Company does not
have any reason to believe that it or any of its Subsidiaries will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business.

 

    	-27-

    	 

    

 

(dd)
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.

 

(ee)
Registration Rights. No Person has any right to cause the Company to effect the registration
under the Securities Act of any securities of the Company or any Subsidiaries.

 

(ff)
Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent
with respect to any of the employees of the Company or any of its Subsidiaries, which could reasonably be expected to result in a Material
Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s
relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining
agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the
Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any
employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does
not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its
Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment
practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(gg)
Dilutive Effect. The Company understands and acknowledges that the number of Conversion Shares issuable upon conversion of the
Notes, the number of Warrant Shares issuable upon exercise of the Warrants, and the number of Commitment Conversion Shares issuable upon
exercise of the Commitment Shares, in each case, pursuant to the terms thereof, will increase in certain circumstances. The Company further
acknowledges that its obligations to issue (i) Conversion Shares pursuant to the terms of the Notes in accordance with this Agreement
and the Notes, (ii) Warrant Shares pursuant to the terms of the Warrants in accordance with this Agreement and the Warrants, and (iii)
Commitment Conversion Shares pursuant to the terms of the Commitment Shares in accordance with this Agreement and the Certificate of
Designation relating to the Commitment Shares, is absolute and unconditional regardless of the dilutive effect that any such issuances
may have on the percentage ownership interests of other stockholders of the Company.

 

    	-28-

    	 

    

 

(hh)
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary action,
if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provisions under the Company’s certificate of incorporation, as amended,
or the laws of the jurisdiction of its formation that are or could become applicable to any Purchaser as a result of the transactions
contemplated by this Agreement and/or the other Transaction Documents, including, without limitation, the Company’s issuance of
the Securities and each Purchaser’s ownership of the Securities. The Company has not adopted a stockholder rights plan or similar
arrangement relating to accumulations of beneficial ownership of Common Stock or a change in control of the Company.

 

(ii)
Manipulation of Price. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result, or that could reasonably be expected to cause or result, in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any person any compensation
for soliciting another to purchase any other securities of the Company.

 

(jj)
DTC Eligible. The Common Stock is DTC eligible and DTC has not placed a “freeze” or a “chill” on the Common
Stock and the Company has no reason to believe that DTC has any intention to make the Common Stock not DTC eligible, or place a “freeze”
or “chill” on the Common Stock. No federal or state regulatory authority has indicated that it will prohibit the listing
of the Company’s securities based upon its prior business in the cannabis or cannabis-related markets nor will any Purchaser be
prohibited from depositing, clearing or settling the Securities, including through the DTC or otherwise, on account of the Company’s
prior business in the cannabis or cannabis-related markets.

 

(kk)
Listing and Maintenance Requirements. The Company has not, in the 12 months preceding the date hereof, received notice from any
Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the
listing or maintenance requirements of such Trading Market. The Common Stock is eligible for quotation on the Principal Market and the
Company has no reason to believe that the Principal Market has any intention of delisting or no longer quoting the Common Stock from
the Principal Market. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading
Market. All Commitment Shares, Commitment Conversion Shares and Warrant Shares have been approved, if so required, for listing or quotation
on the Trading Market, subject only to notice of issuance.

 

(ll)
No General Solicitation. Neither the Company, nor any of its affiliates, nor, to the knowledge of the Company, any Person acting
on its behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection
with the offer or sale of the Securities.

 

    	-29-

    	 

    

 

(mm)
Acknowledgment Regarding Each Purchaser’s Purchase of Securities. The Company acknowledges and agrees that each Purchaser
is acting solely in the capacity of an arm’s length purchaser with respect to the other Transaction Documents and the transactions
contemplated hereby and thereby and that no Purchaser is (i) an officer or director of the Company, (ii) an Affiliate of the Company
or (iii) to the knowledge of the Company, a “beneficial owner” of more than 10% of the shares of Common Stock (as defined
for purposes of Rule 13d-3 of the Exchange Act). The Company further acknowledges that no Purchaser is acting as a financial advisor
or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated hereby and thereby, and any advice given by any Purchaser or any of its representatives or agents in connection
with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such Purchaser’s purchase
of the Securities. The Company further represents to each Purchaser that the decision of the Company and its Subsidiaries to enter into
the Transaction Documents has been based solely on the independent evaluation by the Company, its Subsidiaries and their respective representatives.

 

(nn)
Off-Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its
Subsidiaries and an unconsolidated or other off-balance sheet entity that is required to be disclosed by the Company in its Exchange
Act filings and is not so disclosed.

 

(oo)
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any of its Subsidiaries
to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the
transactions contemplated by the Transaction Documents. No Purchaser shall have any obligation with respect to any fees or with respect
to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with
the transactions contemplated by the Transaction Documents.

 

(pp)
Anti-Money Laundering, Anti-Bribery and Anti-Corruption; Sanctions. 

 

(i)
Neither the Company nor, any of its Subsidiaries or Affiliates or any director or officer of any of them is an individual or entity currently,
or has not in the past 5 years been, subject to any Sanctions or is on any Sanctions List.

 

(ii)
Each of the Company, any of its Subsidiaries and Affiliates and their respective directors, officers, employees and, to the knowledge
of the Company, agents and any other person or entity acting on behalf of the Company, has complied with the Money Laundering, Anti-Corruption
and Anti-Bribery Laws, in each case as applicable to them, and no action, suit or proceeding by or before any court or any arbitrator
or any governmental agency, authority or body involving the Company and any of its Subsidiaries or their respective directors or officers
and, to the knowledge of the Company, the employees, agents, or representatives of each of them, is pending or threatened with respect
to Money Laundering, Anti-Corruption and Anti-Bribery Laws.

 

    	-30-

    	 

    

 

(iii)
Neither the Company nor any of its Subsidiaries nor their respective directors or officers, nor, to the knowledge of the Company, the
employees or agents of any of them has:

 

	 	A.	used
any corporate funds (nor will it use any proceeds from the Notes) for any unlawful contribution, gift, entertainment or unlawful expense
relating to political activity;
	 	 	 
	 	B.	taken
any action in furtherance of an unlawful offer, payment, promise to pay, or authorization or approval of the payment or giving of money,
property, gifts or (anything else of value, directly or indirectly, to any “government official” (including any officer or
employee of a government or government owned or controlled entity or of a public international organization, or any person acting in
an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for public office)
or made any other bribe, rebate, payoff, influence payment or kickback intended to improperly influence official action or secure an
improper advantage;
	 	 	 
	 	C.	nor
will it use any proceeds from the Notes in furtherance of any such unlawful payment or violation of Sanctions or Money Laundering, Anti-Corruption
and Anti-Bribery Laws.

 

(iv)
The Company and each Subsidiary will promote and ensure compliance with Money Laundering, Anti-Corruption and Anti-Bribery Laws in all
jurisdictions where they operate and with the representations and warranties contained herein.

 

(v)
As used in this Section 3.1(pp):

 

	 	A.	“Money
    Laundering, Anti-Corruption and Anti-Bribery Laws” means money laundering and anti- corruption statutes of all jurisdictions
    (including, the Foreign Corrupt Practices Act of 1977, the OECD Convention on Bribery of Foreign Public Officials in International
    Business Transactions, and any similar national or local law or regulation in the United Kingdom or elsewhere where the Company and
    each other Subsidiary conducts business), the rules and regulations thereunder and any related or similar rules, regulations or guidelines,
    issued, administered or enforced by any governmental agency or any such jurisdiction.
	 	 	 
	 	B.	“Sanctions”
means any laws or regulations or restrictive measures relating to economic or financial sanctions or trade embargoes imposed, administered
or enforced from time to time by a Sanctions Authority.

 

    	-31-

    	 

    

 

	 	C.	“Sanctions
    Authority” means (i) the United Nations Security Council; (ii) the United States government; (iii) the European Union;
    (iv) the United Kingdom government; (v) the respective governmental institutions and agencies of any of the foregoing, including
    without limitation, OFAC, the United States Department of State and Department of Commerce, and Her Majesty’s Treasury; and
    (vi) any other governmental institution or agency with responsibility for imposing, administering or enforcing Sanctions with jurisdiction
    over the Company or any of its subsidiaries (together, “Sanctions Authorities”).
	 	 	 
	 	D.	“Sanctions
List” means the Specially Designated Nationals and Blocked Persons List maintained by OFAC, the Denied Persons List maintained
by the U.S. Department of Commerce, the Consolidated List of Financial Sanctions Targets maintained by Her Majesty’s Treasury,
or any other list issued or maintained by any Sanctions Authority of persons subject to Sanctions (including investment or related restrictions),
each as amended, supplemented or substituted from time to time.

 

(qq)
Environmental Laws. The Company and its Subsidiaries, to the best of the Company’s
knowledge, (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health
or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to
emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
(collectively, “Hazardous Materials”) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”);
(ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(rr)
Seniority. As of the Closing Date, (i) all Indebtedness is subordinated to the Notes, and (ii) no Indebtedness or other claim
against the Company is senior to or pari passu with the Notes in right of payment, whether with respect to interest or upon liquidation
or dissolution, or otherwise, other than indebtedness secured by purchase money security interests (which is senior only as to underlying
assets covered thereby) and capital lease obligations (which is senior only as to the property covered thereby).

 

    	-32-

    	 

    

 

(ss)
Licenses; Operating Agreements.

 

(i)
As of the NRJ Acquisition Closing Date and at all times thereafter, each of the Company and its
Subsidiaries has all requisite power and authority, Operating Agreements and Licenses to own and operate its properties and to carry
on its businesses as now conducted and as proposed to be conducted. Schedule 3.1(ss) correctly identifies the call letters and
designated market area of each Station and sets forth all of the material Sharing Arrangements, network affiliation agreements, programming
agreements, franchise agreements and Licenses of the Company and its Subsidiaries with respect to such Station and correctly sets forth
the termination date, if any, of each such Sharing Arrangement, network affiliation agreement, programming agreement, franchise agreement
and License. True, correct and complete copies of each Operating Agreement and License set forth in Schedule 3.1(ss) has been
made available to the Agent. Each material Operating Agreement and License was duly and validly issued pursuant to procedures which comply
in all material respects with all requirements of applicable law, including the Communications Laws. As of the NRJ Acquisition Closing
Date and at all times thereafter, the Company and its Subsidiaries have the right to use all Licenses required in the ordinary course
of business for all Stations, and each such License is in full force and effect. Each of the Company and its Subsidiaries has taken all
actions and performed all of its obligations that are necessary to maintain all Licenses without adverse modification or impairment.
No event has occurred which (A) has resulted in, or after notice or lapse of time or both would reasonably be expected to result in,
revocation, suspension, adverse modification, non-renewal, impairment, restriction or termination of or any order of forfeiture with
respect to, any License or (B) materially and adversely affects or could reasonably be expected in the future to materially and adversely
affect the rights of the Company or any of its Subsidiaries thereunder. Commencing on the date that is 30 days after the NRJ Acquisition
Closing Date, each FCC License is held by a License Sub. None of the FCC Licenses requires that any present stockholder, director, officer
or employee of the Company or any of its Subsidiaries remain a stockholder or employee of such Person, or that any transfer of control
of such Person must be approved by any public or governmental body other than the FCC. 

 

(ii)
Neither the Company nor any of its Subsidiaries is a party to or has knowledge of any investigation,
notice of apparent liability, violation, forfeiture or other order or complaint issued by or before any court or regulatory body, including
the FCC, or of any other proceedings (other than proceedings relating to the radio or television industries generally) which could in
any manner materially threaten or adversely affect the validity or continued effectiveness of the Licenses of any such Person. Neither
the Company nor any of its Subsidiaries has any reason to believe that any Licenses listed and described in Schedule 3.1(ss) will
not be renewed in the ordinary course. Each of the Company and its Subsidiaries, as applicable, (A) has duly filed in a timely manner
all material filings, reports, applications, documents, instruments and information required to be filed by it under the Communication
Act or pursuant to FCC Regulations or requests of any regulatory body having jurisdiction over any of its Licenses, (B) has submitted
to the FCC on a timely basis all required equal employment opportunity reports, and (C) is in compliance with the Communications Laws,
including all FCC Regulations relating to the broadcast of television signals, all FCC Regulations concerning the limits on the duration
of advertising in children’s programming and the record keeping obligations relating to such advertising, the Children’s
Television Act and all FCC Regulations promulgated thereunder and all equal employment opportunity-related FCC Regulations. The Company
and its Subsidiaries maintain appropriate public files at the Stations and at its chief executive office in a manner that complies in
all material respects with all FCC Regulations. 

 

    	-33-

    	 

    

 

(iii)
The Ownership Reports filed by the Company and its Subsidiaries with the FCC are true, correct
and complete in all material respects and there have been no material changes in the ownership of the Company or any Subsidiary of the
Company since the filing of such Ownership Reports other than as described in information filed with the FCC. 

 

3.2
Representation and Warranties of the Purchasers. Each Purchaser, severally and not jointly, hereby represents and warrants as
of the date hereof and as of the Closing Date to the Company as follows:

 

(a)
Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated
or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right,
corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated
by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by
all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each
Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance
with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.

 

(b)
Own Account. Such Purchaser understands that the Securities are “restricted securities”
and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal
for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities
Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities
Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute
or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation
and warranty not limiting such Purchaser’s right to sell the Securities pursuant to an effective registration statement or otherwise
in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary
course of its business.

 

    	-34-

    	 

    

 

(c)
Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as
of the date hereof it is an “accredited investor” as defined in Rule 501(a) under the Securities Act.

 

(d)
Experience of Purchaser. Such Purchaser, either alone or together with its representatives,
has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and
risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is
able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such
investment.

 

(e)
General Solicitation. Such Purchaser is not, to such Purchaser’s knowledge, purchasing
the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper,
magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general
advertisement.

 

(f)
Access to Information. Such Purchaser acknowledges that it has had the opportunity to review
the Transaction Documents (including all exhibits and schedules thereto) and has been afforded (i) the opportunity to ask such questions
as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the
offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and
its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its
investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable
effort or expense that is necessary to make an informed investment decision with respect to the investment. 

 

(g)
Certain Transactions and Confidentiality. Such Purchaser has not directly or indirectly, nor has any Person acting on behalf of
or pursuant to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the
Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company
or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately
prior to the execution hereof. Notwithstanding the foregoing, if such Purchaser is a multi-managed investment vehicle, whereby separate
portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the
investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set
forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision
to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser’s
representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates,
such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence
and terms of this transaction).

 

    	-35-

    	 

    

 

The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such
Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transaction contemplated hereby.

 

ARTICLE
4

OTHER AGREEMENTS OF THE PARTIES

 

4.1
Transfer Restrictions.

 

(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In
connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or
to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor
thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form
and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration
of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be
bound by the terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement.

 

(b)
Each Purchaser agrees to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the
following form:

 

[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON [CONVERSION]
OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL
INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY
SUCH SECURITIES.

 

    	-36-

    	 

    

 

The
Company acknowledges and agrees that each Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor”
as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the provisions of this Agreement and, if required under
the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge
or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor
shall be required in connection therewith. Further, no notice shall be required of such pledge. At such Purchaser’s expense, the
Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in
connection with a pledge or transfer of the Securities, including, if the Securities are then registered for resale on a registration
statement, the preparation and filing of any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable
provision of the Securities Act to appropriately amend the list of selling stockholders thereunder.

 

(c)
Certificates evidencing the Commitment Shares, the Commitment Conversion Shares and/or the Warrant
Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) when they have been
sold while a registration statement (including the Registration Statement) covering the resale
of such security is effective under the Securities Act, (ii) following any sale of such the Commitment Conversion Shares, Conversion
Shares and/or Warrant Shares pursuant to Rule 144, (iii) if such Commitment Conversion Shares, Conversion Shares and/or Warrant Shares
are eligible for sale under Rule 144 and a sale or transfer will be taking place prior to the Company’s next periodic report becomes
due under the Exchange Act or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion
to the Transfer Agent promptly after the Effective Date or at such time as such legend is no longer required under this Section 4.1(c)
if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by any Purchaser. If any portion
of any Note is converted or any portion of any Warrant is exercised at a time when there is an effective registration statement to cover
any sale of the Underlying Shares, or if such Commitment Conversion Shares, Conversion Shares and/or Warrant Shares have been sold under
Rule 144 and the Company is then in compliance with the current public information required under Rule 144, or if the Commitment Conversion
Shares, Conversion Shares and/or Warrant Shares may be sold under Rule 144 without the requirement for the Company to be in compliance
with the current public information required under Rule 144 as to such Commitment Conversion Shares, Conversion Shares and/or Warrant
Shares and without volume or manner-of-sale restrictions provided the conditions of Rule 144(i)(2) have been satisfied and a sale of
such shares will be taking place prior to the Company’s next annual or quarterly report becoming due under its reporting obligations
under the Exchange Act or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission) then such Commitment Conversion Shares, Conversion Shares and/or
Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective Date or at such time as such legend
is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) three (3) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company
or the Transfer Agent of certificate(s) representing the Commitment Conversion Shares, Conversion Shares and/or Warrant Shares, as applicable,
issued with a restrictive legend (such date, the “Legend Removal Date”),
deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other
legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions
on transfer set forth in this Section 4. Certificates for Commitment Conversion Shares, Conversion Shares and/or Warrant Shares
subject to legend removal hereunder shall be transmitted by the Transfer Agent to the applicable Purchaser by crediting the account of
such Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, “Standard
Settlement Period” means the standard settlement period, expressed in a number of Trading
Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate
representing the Commitment Conversion Shares, Conversion Shares and/or Warrant Shares, as applicable, issued with a restrictive legend.

 

    	-37-

    	 

    

 

(d)
In addition to each Purchaser’s other available remedies, the Company shall pay to each Purchaser,
in cash, the greater of (i) as partial liquidated damages and not as a penalty, for each $1,000 of Commitment Conversion Shares, Conversion
Shares and/or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent)
delivered for removal of the restrictive legend and subject to Section 4.1(c), $5 per Trading Day (increasing to $10 per Trading
Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate
is delivered without a legend and (ii) if the Company fails to (x) issue and deliver (or cause to be delivered) to a Purchaser by the
Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive
and other legends or (y) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock,
or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that such Purchaser
anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser’s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the “Buy-In Price”)
over the product of (A) such number of Commitment Conversion Shares, Conversion Shares or Warrant Shares, as applicable, that the Company
was required to deliver to such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock
on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Commitment
Conversion Shares, Conversion Shares or Warrant Shares (as the case may be) and ending on the date of such delivery and payment under
this clause (ii).

 

    	-38-

    	 

    

 

4.2
Furnishing of Information. Beginning on the Closing Date, the Company shall use commercially
reasonable efforts to comply with the Pink Basic Disclosure Guidelines which set forth the disclosure obligations that make up the “Alternative
Reporting Standard” for OTC Pink companies as such obligations are published by the OTC Markets Group, Inc. In addition, the Company
shall file a Registration Statement on Form 8-A as soon as practicable, but in no event no later than five (5) Trading Days, after the
effective date of first registration statement filed by the Company that is declared effective by the SEC which registers securities
held by a Purchaser or any of its Affiliates. If after the date hereof the Company becomes subject to the rules and regulations
of the Exchange Act and as long as any Purchaser owns Securities, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act. As long as any Purchaser
owns Securities, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to each Purchaser
and make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell the Securities,
including without limitation, under Rule 144. In addition, the Company shall file with Commission current “Form 10 information”,
as defined in Rule 144(i)(3), as soon as practicable after the date the Company becomes subject to the rules and regulations of the Exchange
Act, reflecting its status as an entity that is no longer an issuer described in Rule 144(i)(1)(i). The Company further covenants that
it will take such further action as any holder of Securities may reasonably request, to the extent required from time to time to enable
such Person to sell such Securities without registration under the Securities Act, including without limitation, within the requirements
of the exemption provided by Rule 144.

 

4.3
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale
of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would
be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would
require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing
of such subsequent transaction.

 

    	-39-

    	 

    

 

4.4
Securities Laws Disclosure; Publicity. The Company shall by 9:00am on the 2nd Trading Day after the date of this Agreement,
issue a press release disclosing the material terms of the transactions contemplated hereby, which press release shall have been approved
by the Purchasers prior to its release (which approval shall not unreasonably be withheld or delayed). From and after the issuance of
such press release, the Company represents to each Purchaser that it shall have publicly disclosed all material, non-public information
delivered to any Purchaser by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents
in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press
release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written
or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
on the one hand, and any Purchaser or any of its Affiliates on the other hand, shall terminate. The Company and the Purchasers shall
consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company
nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company,
with respect to any press release of any Purchaser, or without the prior consent of the Purchasers, with respect to any press release
of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case
the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not, without the prior written consent of each Purchaser, (a) use the name of any Purchaser, “Arena
Investors LP,” “Arena” or any other derivative thereof (each, a “Trade Name”) in any press releases
or other public disclosures (including in any filing with the Commission or any regulatory agency or Trading Market), offering documents,
sales materials, brochures or similar publicity or promotional materials, or for promotional purposes, whether orally or in writing,
except (x) as required by federal securities law and the rules and regulations promulgated thereunder in connection with the filing of
final Transaction Documents, any disclosure required pursuant to any reports required to be filed by the Company pursuant to the Exchange
Act after the date hereof or the Registration Statement with the Commission, (y) to the extent such disclosure is required by law or
Trading Market regulations, including the “Alternative Reporting Standard” required
by OTC Markets, in which case the Company shall provide each Purchaser with prior notice of such disclosure permitted under this
clause (y), or (z) as required under Nevada General Corporation Law or (b) represent that an investment in the Company or any product
or any service provided by the Company has been approved or endorsed by any Purchaser. Following any such written consent, which
shall not be unreasonably withheld or delayed, the Company shall provide each Purchaser with a copy of such written or other materials
using the Trade Name if requested by any Purchaser. Each Purchaser shall be deemed to have provided prior written consent of the disclosure
of such Purchaser’s name to other stockholders and investors in the Company, and to potential investors in the Company (that to
the extent such information has not already been publicly disclosed, have been informed of the confidential nature thereof) that in the
course of their due diligence require disclosure of the identity of the existing investors in the Company.

 

4.5
Shareholder Rights Plan. No claim will be made or enforced by the Company or, with the consent
of the Company, any other Person, that any Purchaser is an “Acquiring Person”
under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the
provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents.

 

4.6
Non-Public Information. Except with respect to the material terms and conditions of the
transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants
and agrees that neither it, nor any of its Subsidiaries, nor any other Person acting on behalf of any of the foregoing will provide any
Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public
information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any
material, non-public information to any Purchaser without such Purchaser’s consent,
the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries,
or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries or
any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public
information, provided that such Purchaser shall remain subject to applicable law. To the
extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K or if not subject to the reporting requirements under the Commission, file a press release. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.

 

    	-40-

    	 

    

 

4.7
Use of Proceeds. Subject to the terms and conditions set forth on Schedule 4.7
attached hereto, the Company shall use the net proceeds from the sale of the Securities hereunder
(i) to pay the Deposit and Option Fee under the NRJ Acquisition Agreement, (ii) to fund the consideration for the NRJ Acquisition Agreement
upon the consummation of the acquisition contemplated thereby, and (iii) for other acquisitions and purposes approved in writing by the
Purchasers. Without limiting the foregoing, the Company shall not use any such proceeds: (a) for the satisfaction of any portion of the
Company’s debt, (b) for the redemption of any of its preferred stock, Common Stock or Common Stock Equivalents, (c) for the settlement
of any outstanding litigation or (d) in violation of FCPA, OFAC regulations or Money Laundering, Anti-Corruption and Anti-Bribery Laws.
Notwithstanding the foregoing, the Company may receive permission to use such funds to the extent expressly agreed to in advance, in
writing (including electronic mail) by the Purchasers. Notwithstanding anything to the contrary in the Transaction Documents or otherwise,
neither the Company nor its Subsidiaries may use any portion of the Purchase Price or any other proceeds from the Purchasers or
any of their respective Affiliates to pay any liquidated damages, penalties, fees or other amounts due and payable to any Purchaser or
its Affiliates under the Transaction Documents or otherwise without the express advance written consent of the Purchasers (including
at the election of the Purchasers, in the case of an Event of Default under any Note, to repay the Company’s obligations under
any Note, including the outstanding principal amount of any Note, accrued but unpaid interest, liquidated damages and/or other amounts
owing in respect thereof through the date of acceleration using the proceeds in the Funding Account). For
the avoidance of doubt, the net proceeds from the Sale of the Securities hereunder shall be distributed as set forth in Section 2.5
hereof on the Closing Date, and amounts deposited in the Funding Account on the Closing Date shall be further distributed to the
Company as set forth in Section 2.5 hereof. 

 

    	-41-

    	 

    

 

4.8
Indemnification of Purchasers. Subject to the provisions of this Section 4.8, the
Company will indemnify and hold the Agent, each Purchaser and their respective directors, officers, shareholders, members, partners,
employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack
of such title or any other title), each Person who controls any Purchaser (within the meaning of Section 15 of the Securities Act and
Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons
with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such
controlling persons (each, a “Purchaser Party”) harmless from any and
all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, as incurred, arising out of or relating to
(i) any untrue or alleged untrue statement of a material fact contained in any registration statement filed by the Company, any prospectus
or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the
case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to
the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser
Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection
therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to such Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing,
(y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party
effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or
defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause
of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant
to law. 

 

4.9
Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company
shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock equal
to the Required Minimum (as defined in the Notes) for the purpose of enabling the Company to issue the Conversion Shares and any other
shares that may be issuable pursuant to the Notes. If, on any date, the number of authorized but unissued (and otherwise unreserved)
shares of Common Stock is less than the Required Minimum on such date, then the Board of Directors shall use commercially reasonable
efforts to amend the Company’s certificate or articles of incorporation to increase the number of authorized but unissued shares
of Common Stock to at least the Required Minimum at such time, as soon as possible and in any event not later than the 75th day after
such date

 

    	-42-

    	 

    

 

4.10
Listing of Common Stock. The Company hereby agrees to use reasonable best efforts to maintain
the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing,
the Company shall apply to list or quote all of the Commitment Conversion Shares, Conversion Shares and Warrant Shares on such Trading
Market and promptly secure the listing of all of the Commitment Conversion Shares, Conversion Shares and Warrant Shares on such Trading
Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market (including in
accordance with Section 4.23), it will then include in such application all of the Commitment Conversion Shares, Conversion Shares
and Warrant Shares, and will take such other action as is necessary to cause all of the Commitment Conversion Shares, Conversion Shares
and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action
reasonably necessary to continue the listing and trading of its Common Stock on such Trading Market and will comply in all respects with
the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain
the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation,
including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation
in connection with such electronic transfer.

 

4.11
Certain Transactions and Confidentiality. Each Purchaser covenants, severally, but not jointly
or jointly and severally, that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute
any purchases or sales, including Short Sales of any of the Company’s securities during the period commencing with the execution
of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4. Each Purchaser covenants, severally, but not jointly or jointly and
severally, that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to
the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms
of this transaction and the information included in the Disclosure Schedules. Notwithstanding the foregoing and notwithstanding anything
contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the
transactions contemplated by this Agreement are first publicly announced, (ii) no Purchaser shall be restricted or prohibited from effecting
any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4,
(iii) no Purchaser has been asked by the Company to agree, nor has any Purchaser
agreed, to desist from purchasing or selling Securities which have been issued under the terms of this Agreement, any Note, any Warrant
or any other Transaction Document, or “derivative” securities based on securities issued by the Company or to hold the Securities
for any specified term, (iv) no Purchaser shall be deemed to have any affiliation with or control over any arm’s length counter-party
in any “derivative” transaction, (v) any Purchaser may engage in hedging activities, other than Short Sales at various times
during the period that the Securities are outstanding, and (vi) no Purchaser shall have any duty
of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after the issuance of the
initial press release. Except as contemplated above, Company acknowledges that such aforementioned hedging activities do not constitute
a breach of any of the Transaction Documents.

 

    	-43-

    	 

    

 

4.12
Conversion and Exercise Procedures. The form of Notice of Conversion in the Notes sets forth
the totality of the procedures required of the Purchasers in order to convert the Notes, the form of Delivery Notice in the Certificate
of Designation regarding the Commitment Shares sets forth the totality of the procedures required of the Purchasers in order to convert
the Commitment Shares and the form of Notice of Exercise in the Warrants sets forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of any Purchaser
to convert the Notes or the Commitment Shares or exercise the Warrants. Without limiting the preceding sentences, no ink-original
Notice of Conversion, Notice of Exercise or Delivery Notice shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Conversion form, Notice of Exercise form or Delivery Notice form
be required in order to covert the Notes or the Commitment Shares or exercise the Warrants. The Company shall honor conversions of the
Notes and the Commitment Shares and exercises of the Warrants, and shall deliver the Conversion Shares, Commitment Conversion Shares
and the Warrant Shares, as applicable, in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.13
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the
Securities with the Commission as required under Regulation D, and with the applicable securities regulators in the states in which the
Securities were sold, and to provide copies thereof, promptly upon request of any Purchaser. The Company shall take such further action
as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to
the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall
provide evidence of such actions promptly upon request of any Purchaser.

 

4.14
Maintenance of Property. So long as any Note remains outstanding, the Company shall use its commercially reasonable efforts to
keep, and cause each of its Subsidiaries to keep, all of their respective properties, which are necessary or useful to the conduct of
their business, in good working order and condition, ordinary wear and tear excepted.

 

4.15
Preservation of Corporate Existence. So long as any Note remains outstanding, the Company shall, and shall cause each of its Subsidiaries
to, preserve and maintain their respective corporate existences, rights, privileges and franchises in their respective jurisdictions
of incorporation, and qualify and remain qualified, as a foreign corporation in each jurisdiction in which such qualification is necessary
in view of their respective businesses and operations and where the failure to qualify or remain qualified would reasonably be expected
to have a Material Adverse Effect.

 

4.16
DTC Program. At all times that the Securities are outstanding, the Company will employ as the transfer agent for the Common Stock,
the Commitment Shares, the Commitment Conversion Shares, the Conversion Shares and the Warrant Shares a participant in the Depository
Trust Company Automated Securities Transfer Program and cause the Common Stock (including the Commitment Shares, the Commitment Conversion
Shares, the Conversion Shares and the Warrant Shares) to be transferable pursuant to such program.

 

    	-44-

    	 

    

 

4.17
Subsequent Equity Sales. So long as any Note remains outstanding, the Company shall be prohibited from effecting or entering into
an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. “Variable Rate Transaction” means a transaction which is
not Permitted Indebtedness and in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price
or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock
at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is
subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified
or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters
into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may
issue securities at a future determined price. The foregoing restrictions shall not include any agreement for an at-the-market offering.
Each Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be
in addition to any right to collect damages.

 

4.18
Transfer Agent Instructions. The Company shall issue irrevocable instructions to the Transfer Agent in a form acceptable to the
Purchasers (the “Irrevocable Transfer Agent Instructions”) to issue certificates or credit shares via DWAC or otherwise
to the applicable balance accounts at The Depository Trust Company (“DTC”), registered in the name of the Purchasers
and/or their respective nominee(s), for the Underlying Shares in such amounts as specified from time to time by the Purchasers to the
Company upon conversion of the Notes and/or exercise of the Warrants and for the Commitment Shares. The Company represents and warrants
that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section will be given by the Company to
its Transfer Agent with respect to the Securities, and that the Securities shall otherwise be freely transferable on the books and records
of the Company, as applicable, to the extent provided in this Agreement and the other Transaction Documents. In the event that such sale,
assignment or transfer involves Commitment Conversion Shares, Conversion Shares or Warrant Shares sold, assigned or transferred pursuant
to an effective registration statement or in compliance with Rule 144, the transfer agent shall issue such shares to such buyer, assignee
or transferee (as the case may be) without any restrictive legend in accordance with Section 4.1. The Company acknowledges that
a breach by it of its obligations hereunder will cause irreparable harm to the Purchasers. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this Section will be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that each Purchaser shall be entitled, in addition to all other available remedies,
to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing
economic loss and without any bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred
to in the Irrevocable Transfer Agent Instructions to the Company’s transfer agent from and after the Applicable Date. Any fees
(with respect to the transfer agent, counsel to the Company or otherwise) associated with the issuance of such opinion or the removal
of any legends on any of the Securities shall be borne by the Company. “Applicable Date” means the first date on which
all of the Commitment Shares and Underlying Shares are eligible to be resold by the Purchasers pursuant to Rule 144 or an effective registration
statement is in effect.

 

    	-45-

    	 

    

 

4.19
Public Information. At any time during the period commencing from the six (6) month anniversary of the Closing Date and ending
at such time that all of the Securities, may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1)
and otherwise without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to satisfy the current
public information requirement under Rule 144(c) (a “Public Information Failure”) then, in addition to the Purchasers’
other available remedies, the Company shall pay to each Purchaser, in cash, as partial liquidated
damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal
to two percent (2.0%) of the aggregate Purchase Price of each Purchaser’s Securities
on the day of a Public Information Failure and on every thirtieth (30th) day (prorated for periods totaling less than thirty
days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information
is no longer required for the Purchasers to transfer the Underlying Shares pursuant to Rule 144. The payments to which the
Purchasers shall be entitled pursuant to this Section 4.19 are referred to herein as “Public Information Failure
Payments.” Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during
which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure
giving rise to the Public Information Failure Payments is cured. If an Event (as defined in the Registration Rights Agreement) is occurring
at the time of a Public Information Failure, and the Company is (x) then obligated to pay, and (y) timely pays the Purchasers partial
liquidated damages under Section 2(d) of the Registration Rights Agreement for the period occurring simultaneous with the applicable
Public Information Failure (such payments, the “Simultaneous Registration Rights Partial Liquidated Damages”) and
(z) has timely paid the Purchasers all previously accrued partial liquidated damages under Section 2(d) of the Registration Rights
Agreement, the Company may deduct the amounts paid in connection with such Simultaneous Registration Rights Partial Liquidated Damages
from such Public Information Failure Payments due for such simultaneous Public Information Failure. In the event the Company fails to
make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate
of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit any Purchaser’s right to pursue
actual damages for the Public Information Failure, and each Purchaser shall have the right
to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief.

 

4.20
Subsequent Equity Financing. Within thirty (30) calendar days of the Closing Date (the “Subsequent Equity Financing Deadline
Date”), the Company shall sell in one or more closings shares of preferred stock (which may be convertible into shares of Common
Stock) on terms reasonably acceptable to the Purchasers (the “Subsequent Equity Financing”) for aggregate gross proceeds
equal to or exceeding $3,000,000 (“Subsequent Equity Financing Closing”), which Subsequent Equity Financing shall
not be subject to the issuance of any warrants or similar equity securities. To the extent the Subsequent Equity Financing Subsequent
Closing does not occur on or prior to the Subsequent Equity Financing Deadline Date, then, in addition to the
Agent’s and each Purchaser’s other available remedies, an amount in cash, as partial liquidated damages and not as
a penalty, shall be payable by the Company to the Purchasers equal to $60,000 on the day of the Subsequent Equity Financing Deadline
Date and on every thirtieth (30th) day (prorated for periods totaling less than thirty days) thereafter until the Subsequent
Equity Financing Closing occurs; provided, the amount set forth above shall increase by $30,000 on every thirtieth (30th)
day after the Subsequent Equity Financing Deadline Date if such closing(s) for the Subsequent Equity Financing have not taken place.
The payments to which the Purchasers shall be entitled pursuant to this Section 4.20
are referred to herein as “Subsequent Equity Financing Failure Payments.” Subsequent Equity Financing Failure
Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Subsequent Equity Financing Failure
Payments are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Subsequent Equity
Financing Failure Payments is cured. The Company acknowledges and agrees that if the Subsequent Equity Financing Closing does not occur
by the Subsequent Equity Financing Deadline Date, it shall be an Event of Default (as defined in the Notes) under the Notes, notwithstanding
the payment of the Subsequent Equity Financing Failure Payments.

 

    	-46-

    	 

    

 

4.21
Litigation and Other Notices. For as long as any Note remains outstanding, the Company shall promptly, to the extent not prohibited
by law, give each Purchaser notice in writing of:

 

(a)
within three Trading Days following the knowledge by the Company thereof, any Action before or by any court,
arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) affecting
the Company, any Subsidiary, any director and/or officer including but not limited to, any Action involving
a claim of violation of or liability under federal or state securities laws, a claim of breach of fiduciary duty or any investigation
by a governmental or administrative agency or regulatory authority (federal, state county, local or foreign);

 

(b)
within three Trading Days following the occurrence thereof, any Default or Event of Default or event that has had or could reasonably
be expected to have a Material Adverse Effect;

 

(c)
upon the consummation of any acquisition or investment by the Company or any of its Subsidiaries and as and at the end of each fiscal
year, a restatement of Schedule 3.1(ss) hereto with respect to the following items: (i) the call letters and designated market
area of each Station, (ii) all of the network affiliation agreements for the primary channel of such Station, (iii) the FCC Licenses
of the Company and its Subsidiaries with respect to such Stations and (iv) the termination date, if any, of each such network affiliation
agreement and FCC License;

 

(d)
promptly upon their becoming available, copies of (i) all press releases and other statements made available generally by the Company
or any of its Subsidiaries to the public concerning material developments in the business of the Company or any of its Subsidiaries,
(ii) any material non-routine correspondence or official notices received by the Company, or any of its Subsidiaries from the FCC or
other communications regulatory authority, and (iii) all material information filed by the Company or any of its Subsidiaries with the
FCC; and

 

    	-47-

    	 

    

 

(e)
within three Trading Days following receipt of notice thereof (i) any forfeiture, non-renewal, cancellation, termination, revocation,
suspension, impairment or material modification of any material License held by the Company or any of its Subsidiaries, or any notice
of default or forfeiture with respect to any such License, (ii) any complaint or other matter filed with or communicated to the FCC or
other Governmental Authority of which the Company and any of its Subsidiaries has knowledge which, individually or in the aggregate,
could reasonably be expected to have a Material Adverse Effect, or (iii) any lapse, termination or relinquishment of any material License
held by the Company or any of its Subsidiaries, or any refusal by any Governmental Authority or agency (including the FCC) to renew or
extend any such License.

 

Any
such information provided to any Purchaser shall comply with the requirements of Section
4.6 above.

 

4.22
Access to Records. The Company shall and shall cause each of its Subsidiaries to provide the Agent and each
Purchaser and/or any of their respective duly authorized representatives, attorneys or accountants access to any and all bank
records at the premises of the Company or such Subsidiary where such records are kept, such access being afforded without charge, but
only during normal business hours. Any such information provided to the Agent or any Purchaser
shall comply with the requirements of Section 4.6 above.

 

4.23
OTC Markets; National Securities Exchange. 

 

(a)
Except as otherwise provided in clause (b) below, the Company shall take all necessary and appropriate
actions to ensure that its shares of Common Stock remain listed and quoted on the OTCQB or OTCQX at all times.

 

(b)
As soon as reasonably practicable after the Company meets the qualitative and quantitative listing
standards for listing on a national securities exchange, the Company shall use reasonable best efforts to take all necessary and appropriate
actions to list its shares of Common Stock for trading on such national securities exchange.

 

4.24
Post-Closing Actions. The Company shall and shall cause each of its relevant Subsidiaries
to execute and deliver the documents and complete the tasks set forth in this Section as soon as reasonably practicable and in each case
no later than the time limit specified in this Section or such longer time as the Purchasers may agree in their sole discretion:

 

(a)
Not later than ten (10) calendar days after the Closing Date, the Company shall deliver to the
Agent (i) original certificates representing the equity interests required to be pledged under the Security Agreement and the Individual
Pledge Agreement, in each case, accompanied by appropriate transfer powers, duly executed in blank;

 

(b)
Not later than thirty (30) calendar days after the Closing Date, the Company and each of its Subsidiaries
shall deliver to the Agent, in form and substance reasonably satisfactory to Agent, Control Agreements, in form and substance satisfactory
to the Agent, with respect to each of its deposit accounts and securities accounts;

 

    	-48-

    	 

    

 

(c)
Not later than the NRJ Acquisition Closing Date, copies of insurance certificates describing all insurance policies maintained by the
Company and its Subsidiaries (which shall include liability insurance and property insurance in amounts and otherwise on terms reasonably
satisfactory to Agent), together with mortgagee, lender loss payable and additional insured endorsements in favor of Agent; and

 

(d)
Any Person acquired by the Company or any of its Subsidiaries, or that otherwise becomes a direct or indirect Subsidiary of the Company,
on or after the date of this Agreement shall enter into a Subsidiary Guaranty Agreement and be joined to the Security Agreement as a
debtor not later than one (1) calendar day after the consummation of such acquisition by the Company or such Subsidiary or the date the
Person otherwise becomes a Subsidiary of the Company or such Subsidiary.

 

4.25
Future Financings. Except for Permitted Indebtedness and for so long as Liabilities are
outstanding, neither the Company, nor any of its Subsidiaries, shall enter into, create, incur, assume, guarantee or suffer to
exist any Indebtedness. Despite the foregoing prohibition and for so long as Liabilities are outstanding, if at any time the Company
or any of its Subsidiaries issues or incurs any Indebtedness other than Permitted Indebtedness, in addition to the Agent’s and
the Purchasers’ other available remedies, the Company shall pay to the Purchasers, in cash, as partial liquidated damages and not
as a penalty, on each date of any such issuance or incurrence of Indebtedness, $30,000. Any such Indebtedness shall be expressly subordinated
to the Notes, and the holders of such Indebtedness shall not be granted any registration rights, nor shall the Company register, or cause
to be registered, with the SEC or any state securities commission the notes or other debt instruments representing such Indebtedness
or any equity securities issuable in connection with such Indebtedness. In addition, the Company shall not grant any registration rights
in connection with the Subsequent Equity Financing, nor shall the Company register, or cause to be registered, with the SEC or any state
securities commission any equity securities issuable in connection with the Subsequent Equity Financing.

 

4.26
License Subs. At the time of any acquisition or investment permitted hereunder and under
the Notes, the Company shall cause each of the FCC Licenses being acquired by the Company or any of its Subsidiaries to be transferred
to one or more License Subs, each of which License Subs shall have as its sole asset or assets the FCC Licenses of the Company or any
of its Subsidiaries and a management agreement with the Company and such of its Subsidiaries subject to such FCC License or FCC Licenses,
such that from and after such applicable date neither the Company nor its Subsidiaries (other than License Subs) shall hold any FCC Licenses
other than through one or more duly created and existing License Subs. The Company shall not permit the License Subs to have any business
activities, operations, assets, Indebtedness, Contingent Obligations or Liens (other than holding FCC Licenses, being a party to network
affiliation agreements and owning the equity interests of other License Subs, and its obligations under the Transaction Documents). Promptly
after the transfer of the FCC Licenses to the License Subs, the Company shall, upon the request of the Agent, provide to the Agent copies
of any required consents to such transfer from the FCC and any other governmental authority which such consents shall be in full force
and effect and not subject to any pending reversal or cancellation. 

 

    	-49-

    	 

    

 

4.27
Maintenance of Network Affiliations; Operating Agreements. The Company will, and will cause each of its Subsidiaries to, maintain
one or more network affiliations with networks reasonably satisfactory to the Agent at all times for each Station except where the failure
to maintain such network affiliation could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse
Effect. The Company will, and will cause each of its Subsidiaries to comply with any and all Operating Agreements except where the failure
to so comply could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

4.28
Ownership Reports. The Company will file Ownership Reports for any Station acquired after the Closing Date (reflecting such acquisition
by the Company or its Subsidiaries) with the FCC within the time frames required under applicable law, including the Communications Laws.

 

4.29
Licenses and Operating Agreements. The Company will cause each of the representations and warranties contained in Section 3.1(ss)
to be true and correct at all times.

 

4.30
Company as Holding Company. Notwithstanding anything to the contrary contained herein or in the other Transaction Documents, the
Company will have (a) no assets (other than deposit accounts and the ownership of its Subsidiaries), (b) no liabilities (other than under
the Transaction Documents) and (c) no business operations (other than the ownership of its Subsidiaries and activities required to maintain
its status as a public company).

 

4.31
Negative Covenants. The Company shall company and cause its Subsidiaries to comply with the negative covenants contained in Section
7 of the Note.

 

4.32
Right of First Refusal.

 

(a)
The Company, on behalf of itself and each of its Subsidiaries, hereby grants to the Purchasers a right of first refusal to provide any
Additional Financing to be sought by the Company and/or any of its Subsidiaries or other Affiliates (directly or indirectly, including
through special purpose vehicles or joint ventures) (each, an “Offeror” and collectively, the “Offerors”),
subject to the following terms and conditions (the “Right of First Refusal”). Such Right of First Refusal shall expire
upon the earlier of (i) the date on which the Purchasers have provided $50,000,000 of Additional Financing to the Offerors, and (ii)
the date that is twelve months following the Closing Date.

 

(b)
Without derogating from any other provision under this Agreement, from and after the Closing Date, prior to the consummation of any Additional
Financing with other lenders and finance providers, each Offeror shall notify each Purchaser of its intention to obtain such Additional
Financing. In connection therewith, such Offeror shall deliver to each Purchaser a written notice setting forth all of the terms and
conditions of any such Additional Financing proposed to be entered into, along with a binding commitment letter from the lender or finance
provider that has agreed to provide such Additional Financing to such Offeror (the “Financing Notice”).

 

    	-50-

    	 

    

 

(c)
If a Purchaser wishes to exercise the Right of First Refusal, such Purchaser must provide notice of its election to provide such Additional
Financing upon the same terms and provisions in the Financing Notice (the “ROFR Election Notice”), within five (5)
Business Days of its receipt of the Financing Notice. Upon receipt of the ROFR Election Notice by an Offeror, such Offeror and such Purchaser
shall negotiate in good faith and enter into definitive agreements with respect to the Additional Financing in the ROFR Election Notice
and consummate such transaction within sixty (60) days of receipt of the ROFR Notice by Offeror.

 

(d)
If (i) no Purchaser elects to exercise the Right of First Refusal or (ii) no Purchaser provides its response to the Financing Notice
within such fourteen (14) Business Days, the Purchasers shall be deemed to have waived their Right of First Refusal for the subject Additional
Financing, but not any Right of First Refusal for future Additional Financing. If the Right of First Refusal is deemed waived pursuant
to this Section 4.32, the Offeror shall have the right to negotiate and consummate the Additional Financing described in the Financing
Notice with the lender specified in the Financing Notice on terms not more favorable than the terms described in the Financing Notice,
to be consummated within sixty (60) days from the date of such waiver or deemed waiver by the Purchasers, otherwise such Additional Financing
shall again be subject to the Right of First Refusal set forth in this Section 4.32.

 

(e)
The Company will not, and will not permit any of its Subsidiaries or other Affiliates to, agree, directly or indirectly, to any restriction
with any person or entity which limits the Right of First Refusal.

 

(f)
The provisions of this Section 4.32 shall survive any termination or expiration of this Agreement.

 

ARTICLE
5

MISCELLANEOUS

 

5.1
Fees and Expenses. Except as expressly set forth below and in the Transaction Documents to the contrary, each party shall pay
the reasonable, documented fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses
incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall
pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered
by the Company and any exercise notice delivered by any Purchaser), stamp taxes and other
taxes and duties levied in connection with the delivery of any Securities to any Purchaser. Notwithstanding the foregoing, the Company
agrees to pay all direct and indirect costs and expenses of the Agent and the Purchasers related to the negotiation, due diligence, preparation,
closing, and all other items regarding or related to this Agreement and the other Transaction Documents and all of the transactions contemplated
herein and/or therein, including, but not limited to, the legal fees and expenses of the Agent’s and the Purchasers’ legal
counsel (collectively, the “Purchaser’s Expenses”), all of which will be deducted and paid on Closing Date.

 

5.2
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

    	-51-

    	 

    

 

5.3
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is
delivered via facsimile or email attachment at the facsimile number or email address as set forth on the signature pages attached hereto
at or prior to 5:30 p.m. (New York City time) on a Business Day, (b) the next Business Day after the date of transmission, if such notice
or communication is delivered via facsimile or email attachment at the facsimile number or email address as set forth on the signature
pages attached hereto on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, (c) the second
(2nd) Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon
actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as
set forth on the signature pages attached hereto.

 

5.4
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and the Purchasers or, in the case of a waiver, by the party against whom enforcement
of any such waived provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition
or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise
of any such right. Any amendment effected in accordance with accordance with this Section 5.4 shall be binding upon the Purchasers
and holders of Securities and the Company and its Subsidiaries.

 

5.5
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of the Purchasers. Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities in compliance with the Transaction Documents, provided that such transferee agrees in writing to be
bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers,”
and provided further that (i) such transferee is an “accredited investor” within the meaning of Rule 501 under the Securities
Act and (ii) such transferee is not a direct competitor of the Company or any Subsidiary.

 

5.6
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

    	-52-

    	 

    

 

5.7
Governing Law; Exclusive Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of
the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced
exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company elsewhere in this Agreement, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.

 

5.8
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities at
Closing.

 

5.9
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature
page were an original thereof.

 

5.10
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired, or invalidated, as long as the essential terms and conditions
of the Notes for each party remain valid, binding, and enforceable. The parties shall use their commercially reasonable efforts to find
and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant
or restriction.

 

5.11
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and
without limiting any similar provisions of) any of the other Transaction Documents, whenever the Agent or any Purchaser exercises a right,
election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods
therein provided, then the Agent and/or the Purchasers may rescind or withdraw, in its sole discretion from time to time upon written
notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights;
provided, however, that, in the
case of a rescission of a conversion of a Note, the applicable Purchasers shall be required to return any shares of Common Stock subject
to any such rescinded conversion or exercise notice concurrently with the return to such Purchasers of the aggregate exercise price paid
to the Company for such shares.

 

    	-53-

    	 

    

 

5.12
Replacement of Securities. If any certificate or instrument evidencing any Securities is
mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation
thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt
of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument
under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance
of such replacement Securities.

 

5.13
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Agent, the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties
agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in
the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the
defense that a remedy at law would be adequate.

 

5.14
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser
pursuant to any Transaction Document or the Agent or any Purchaser enforces or exercises its rights thereunder, and such payment or payments
or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, any of its Subsidiaries,
a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be
satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff
had not occurred.

 

5.15
Usury. To the extent it may lawfully do so, the Company hereby agrees not to insist upon
or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of,
usury laws wherever enacted, now or at any time hereafter in force, in connection with any Action or Proceeding that may be brought by
the Agent or any Purchaser in order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the
contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the
Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law
(the “Maximum Rate”), and, without limiting the foregoing, in no event
shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the
Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum contract rate
of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to
the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any
circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Purchasers with respect to indebtedness
evidenced by the Transaction Documents, such excess shall be applied by the Purchasers to the unpaid principal balance of any such indebtedness
or be refunded to the Company, the manner of handling such excess to be at the Purchasers’ election.

 

5.16
Liquidated Damages. The Company’s obligations to pay any partial liquidated damages
or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid
partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which
such partial liquidated damages or other amounts are due and payable shall have been canceled.

 

5.17
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

5.18
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto.

 

5.19
WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

 

(Signature
Pages Follow)

 

    	-54-

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	 	MADISON
    TECHNOLOGIES, INC.
	 	 	 
	 	By:	 
	 	Name:	                           
	 	Title:	 
	 	 	 
	 	Address
    for Notice:
	 	 	 
	 	With
    a copy to (which shall not constitute notice):

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

 

SIGNATURE
PAGE FOR PURCHASERS FOLLOWS]

 

Signature
Page to Securities Purchase Agreement

 

    	 

    	 

    

 

PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT

 

IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

	 	ARENA
    SPECIAL OPPORTUNITIES FUND, LP
	 	 	 
	 	By:	 
	 	Name:	Lawrence
    Cutler
	 	Title:	Authorized
    Signatory
	 	 	 
	 	ARENA
    SPECIAL OPPORTUNITIES PARTNER I, LP 
	 	 	 
	 	By:	 
	 	Name:	Lawrence
    Cutler
	 	Title:	Authorized
    Signatory
	 	 	 
	 	Address
    for Notice to Purchasers:
	 	 
	 	405
    Lexington Avenue, 59th Floor
	 	New
    York, NY 10174
	 	Attention:
    Lawrence Cutler
	 	Email:
    lcutler@arenaco.com
	 	Facsimile:
    212.612.3207
	 	 
	 	Address
    for Delivery of Securities to Purchaser (if not same as address for notice):

 

Signature
Page to Securities Purchase Agreement

 

    	 

    	 

    

 

Schedule
1

Purchase
Price; Securities Purchased

 

	Name of Purchaser	 	Purchase Price	 	 	Aggregate Principal Amount of Notes being Purchased	 	 	Number of Common Shares into which Commitment Shares are Convertible (subject to adjustment)	 	 	Number of Common Shares into which Warrants are Exercisable (subject to adjustment)	 
	Arena Special Opportunities Fund, LP	 	$	4,905,000	 	 	$	5,395,500	 	 	 	62,807,875.559	 	 	 	62,807,875.559	 
	Arena Special Opportunities Partner I, LP	 	$	10,095,000	 	 	$	11,104,500	 	 	 	129,265,140.441	 	 	 	129,265,140.441	 
	TOTAL	 	$	15,000,000	 	 	$	16,500,000	 	 	 	192,073,017	 	 	 	192,073,017

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]